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crucial	 regulators	 of	 oligodendrocyte	 development	 and	 myelination.	 Herein,	 this	 study	
investigates	the	implication	of	Gpr17	in	myelination	in	its	native	signalling	environment	by	using	
zebrafish	(Danio	rerio),	an	ideal	suited	vertebrate	model	system	for	studying	myelination	in	vivo.	
Additionally,	 further	 functionality	 studies	 evaluate	 responsiveness	 of	 zebrafish	 and	 chimeric	
human/zebrafish	Gpr17	receptors	in	extrinsic	mammalian	cellular	backgrounds.	
While	 zebrafish	 Gpr17	 transiently	 transfected	 in	 HEK293	 cells	 remained	 unresponsive	 towards	
the	 small	 molecule	 agonist	 MDL29,951,	 stimulation	 of	 chimeric	 human/zebrafish	 receptors	
containing	 the	 human	 binding	 domain	 led	 to	 concentration-dependent	 response	 curves	 in	
Dynamic	mass	redistribution	assays.	These	results,	further	confirmed	by	 in	vivo	assays	revealing	
unaffected	oligodendrocyte	development	and	myelination	after	bath	treatment	with	MDL29,951,	
imply	an	 impaired	 zebrafish	 receptor-ligand	 interaction	both	 in	 vivo	 and	 in	 vitro.	 Investigations	
with	zebrafish	demonstrated	sustained	Gpr17	expression	in	oligodendrocyte	lineage	cells	during	
CNS	development	from	1	to	5	dpf.	Moreover,	morpholino-induced	receptor	knockdown	provoked	
a	 significant	 reduction	 of	 pre-mature	 and	 mature	 oligodendrocyte	 numbers	 and	 disturbed	
myelination.	 The	 reduced	 cell	 numbers	 are	 assumed	 to	 result	 from	 impaired	migration	 of	 pre-
mature	 pre-oligodendrocytes	 (pre-OLs)	 accumulating	 in	 the	 ventral	 spinal	 cord	 region.	 On	 the	
contrary,	 overexpression	 of	 Gpr17	 in	 early	 stages	 did	 not	 influence	 oligodendrocyte	
development.	Together,	the	data	confirm	a	crucial	role	of	zebrafish	Gpr17	in	vivo.	Clearly,	future	









Im	 zentralen	 Nervensystem	 (ZNS)	 stellt	 die	 Myelinisierung	 durch	 Gliazellen,	 den	 sogenannten	
Oligodendrozyten,	 eine	 essentielle	 Grundlage	 für	 die	 erfolgreiche	 Reizweiterleitung	 von	
Nervenzellen	 dar.	 Trotz	 zahlreicher	 Studien	 bestehen	 jedoch	 weiterhin	 Unklarheiten	 bezüglich	
der	Entwicklung	von	Oligodendrozyten	sowie	ihrer	Aufgabe	Myelin	zu	produzieren.	Permanente	
Forschung	 in	 diesem	 Gebiet	 hat	 kürzlich	 erwiesen,	 dass	 G-Protein-gekoppelte	 Rezeptoren	
(GPCRs),	wie	 etwa	Gpr17,	 entscheidende	 Rollen	 in	 der	 Reifung	 von	Oligodendrozyten	 sowie	 in	
der	Myelinisierung	übernehmen.	 Innerhalb	dieser	Arbeit	wurde	der	Zebrafisch	 (Danio	 rerio)	als	
Tiermodell	 verwendet,	 um	den	 Einfluss	 von	Gpr17	 auf	 die	Myelinisierung	 zu	 untersuchen.	 Des	
Weiteren	 wurden	 der	 Zebrafisch-Gpr17	 sowie	 chimäre	 Human/Zebrafisch-Rezeptoren	 auf	 ihre	
Funktionalität	gegenüber	postulierten	Gpr17	Liganden	in	zellulären	Hintergründen	überprüft.	
Während	der	Agonist	MDL29,951	den	in	HEK293	Zellen	rekombinant	überexprimierten	Zebrafish-
Gpr17	 nicht	 zu	 aktivieren	 vermochte,	 führte	 die	 Stimulation	 von	 chimären	 Human/Zebrafisch-
Rezeptoren	 zu	 einer	 konzentrationsabhängigen	 Zellantwort	 in	 dynamischen	
Massenumverteilungs-Experimenten.	 Diese	 Ergebnisse	 wurden	 durch	 weitere	 in	 vivo	 Studien	




Der	 zweite	 Teil	 dieser	 Arbeit	 befasste	 sich	 mit	 der	 Expression	 und	 der	 Rolle	 von	 Gpr17	 im	
Zebrafisch.	Zunächst	konnte	bewiesen	werden,	dass	Gpr17	innerhalb	der	ersten	5	Tage	während	
der	 ZNS	 Entwicklung	 von	 unreifen	 Oligodendrozyten-Vorläufer-Zellen	 exprimiert	 wird.	 Um	
weitere	 Rückschlüsse	 auf	 den	 Einfluss	 von	 Gpr17	 auf	 die	 Oligodendrozyten-Reifung	 zu	 ziehen,	
wurde	 mittels	 Morpholino-Injektion	 ein	 Rezeptor-Knockdown	 hervorgerufen,	 der	 eine	
signifikante	 Reduktion	 von	 unreifen	 sowie	 reifen	 Oligodendrozyten	 im	 dorsalen	
Rückenmarksbereich	 und	 eine	 gestörte	Myelinisierung	 zur	 Folge	 hatte.	 Hierbei	 wird	 vermutet,	
dass	 die	 Abwesenheit	 von	 Gpr17	 nicht	 nur	 die	 Reifung,	 sondern	 auch	 die	 Migration	 von	
Oligodendrozyten	 zu	 den	 Axonen	 beeinträchtigt.	 Im	 Gegensatz	 zum	 Rezeptor-Knockdown	
bewirkte	die	Überexpression	von	Gpr17	in	frühen	embryonalen	Phasen	keinerlei	Veränderung	in	














































































































































The	 central	 nervous	 system	 (CNS)	 consists	 of	 giant	 cells	 conducting	 electrical	 signals	 over	 long	
distances	 throughout	 the	 body	 of	 living	 beings	 to	 innervate	 their	 targets.	 These	 cells	 called	
neurons	exhibit	 large	calibre	axons	that	are	wrapped	in	multilamellar	 insulating	myelin	sheaths.	
Through	periodic	unmyelinated	breaks	on	the	neuronal	plasma	membrane,	the	nodes	of	Ranvier,	
enormous	 velocities	 of	 saltatory	 conduction	 between	 neurons	 and	 their	 targets	 are	 achieved	
(Hartline	 and	 Colman,	 2007)	 allowing	 rapid	 physiological	 reactions.	 The	 importance	 of	
myelination	 in	 the	 CNS	 is	 underscored	 by	 several	 destructive	 neurological	 disorders	 such	 as	
multiple	 sclerosis	 (MS),	 an	 inflammatory	 autoimmune	 disease	 caused	 by	 myelin	 sheath	
breakdown	 (Compston	 and	 Coles,	 2008).	 Moreover,	 Alzheimer’s	 disease	 (George	 Bartzokis,	
2011),	 cerebral	 palsy	 (Azzarelli	 et	 al.,	 1996)	 or	 schizophrenia	 (Azzarelli	 et	 al.,	 1996)	 display	
abundance	 of	 demyelination.	 Although	 a	 range	 of	 studies	 unveiled	 distinct	 signalling	 cascades	
controlling	myelination	 of	 axons	 (Marinelli	 et	 al.,	 2016),	 the	 complex	molecular	mechanism	 of	
myelin	synthesis	remain	poorly	explored.	Thus,	there	is	an	urgent	need	of	fundamental	research	
to	identify	candidate	pathways,	targets	and/or	therapeutic	molecules	that	promote	myelination	
when	 endogenous	 remyelination	 fails.	While	 in	 vitro	 studies	 help	 to	 uncover	 key	molecules	 or	
downstream	 signalling	 cascades,	 in	 vivo	 models	 such	 as	 zebrafish	 present	 an	 ideal	 system	 to	
investigate	myelination	in	its	native	signalling	environment	(Preston	and	Macklin,	2015).	









generate	 axon-wrapping	 myelin	 sheaths	 that	 promote	 rapid	 conduction	 of	 action	 potentials	









oligodendrocytes	 forming	 compact	 multilayer	 membrane	 sheaths,	 the	 myelin.	 This	 process	 is	
called	myelination	and	is	accompanied	by	the	expression	of	a	variety	of	terminal	markers	such	as	





Figure	 1:	 Oligodendrocyte	 development	 (Oligodendrogenesis)	 in	 zebrafish.	Neural	 precursor	 (NP)	 cells	
give	 rise	 to	 oligodendrocyte	 precursor	 cells	 (OPCs)	 within	 the	 pMN	 domain	 of	 the	 neural	 tube.	 OPCs	
expressing	 Olig2	 proliferate	 and	 start	 migrating	 dorsally	 throughout	 the	 developing	 CNS.	 The	 onset	 of	
terminal	 differentiation	 into	 pre-oligodendrocytes	 (pre-OLs)	 is	 accompanied	 by	 the	 expression	 of	 the	
transcription	 factor	Nkx2.2.	 Pre-OLs	 extent	processes	 that	wrap	axons,	 but	do	not	myelinate	 yet.	 Finally	
pre-OLs	 transition	 into	 mature	 myelin-producing	 oligodendrocytes	 (OLs).	 Shown	 are	 lateral	 images	 of	




vertebrate	 system,	 but	 also	 persists	 until	 adulthood.	 Healthy	 adults	 display	 an	 increase	 of	
myelination,	peaking	in	the	mid-30s,	that	declined	again	beyond	the	middle	age	(Lu	et	al.,	2013).	
Meanwhile,	it	is	known	that	myelination	is	not	only	required	for	efficient	saltatory	conduction	of	
action	 potentials	 but	 also	 contributes	 to	 the	 stability	 and	 health	 of	 axons.	 Furthermore,	 it	 is	
assumed	that	myelination	is	necessary	for	higher	cognitive	function	during	learning	phases	both	
in	 child	 and	 adulthood	 (Emery,	 2010;	 Nave,	 2010).	 Thereby,	 adult	 OPCs	 remaining	 in	 the	 CNS	
retain	 the	 capability	 of	 proliferating	 and	 dividing	 into	mature	myelinating	 oligodendrocytes	 in	
health	and	also	in	disease	(Harlow,	Honce	and	Miravalle,	2015).		
Loss	 of	 myelin	 during	 young	 adulthood,	 a	 defining	 pathological	 feature	 of	 demyelinating	
disorders	 such	 as	 multiple	 sclerosis	 (MS)	 (Compston	 and	 Coles,	 2008),	 can	 be	 rescued	 by	
endogenous	 regenerative	 remyelination	 through	 adult	 OPCs.	 However,	 this	 repair	 exhibits	
abnormalities	 in	myelin	 thickness	 and	 fails	 as	 the	 disease	 progresses	 (Perier,	 O.	 and	 Gregoire,	
1965;	 van	 Wijngaarden	 and	 Franklin,	 2013).	 Ongoing	 research	 has	 discovered	 impaired	























neurons	 in	 demyelinating	 injuries	 (Hagemeier,	 2012).	 Hence,	 the	 identification	 of	 potential	
remyelinating	 strategies	 that	 promote	 the	 survival	 and	 maturation	 of	 oligodendrocytes	 could	
restore	neuronal	function	and	prevent	clinical	disabilities.		
Though	 the	 repair	 mechanism	 is	 unknown,	 previous	 studies	 reported	 that	 established	
immunomodulatory	 therapies	 induce	 beneficial	 consequences	 on	 remyelination	 in	 animal	
models.	However,	MS	patients	treated	with	immunomodulators	still	revealed	damaged	myelin	in	
the	 progressive	 phase	 of	 the	 disease	 (Aharoni	 and	 Aharoni,	 2016).	 Promising	 results	 were	
achieved	with	 a	monoclonal	 antibody	 (Opicinumab)	 targeted	 to	 the	 Nogo	 receptor	 interacting	
protein-1	 (Lingo-1),	 a	 protein	 negatively	 regulating	 both	 oligodendrocyte	 maturation	 and	
myelination.	 Inhibition	 of	 Lingo-1	 promotes	 remyelination	 in	 vitro	 and	 in	 vivo	 (Mi	et	 al.,	 2005,	
2007;	Pepinsky	et	al.,	2011),	hence	it	was	evaluated	in	clinical	trials.	Although	Opicinumab	failed	






Noteworthy,	 a	 large	number	of	 nuclear	 (Marinelli	et	 al.,	 2016)	 and	 guanine	nucleotide	binding	
protein	 (G-protein)	 receptors	 (Mogha,	 Rozario	 and	 Monk,	 2016)	 have	 been	 identified	 to	







The	 guanine	 nucleotide	 binding	 protein	 receptors	 (GPCRs)	 present	 the	 largest	 membrane	
receptor	family	of	pharmacological	drug	targets	in	the	mammalian	genome	(Bjarnadóttir,	2006).	
Involved	 in	a	 variety	of	physiological	 events,	many	distinct	diseases	 such	as	 cardiovascular	 and	
neurodegenerative	 disorders	 or	 cancer	 can	 be	 modulated	 through	 their	 selective	 activation	
(Neves,	 Ram	 and	 Iyengar,	 2002;	 Howard	 et	 al.,	 2011).	 Intriguingly,	 recent	 studies	 implicate	
manifested	key	roles	of	GPCRs	in	PNS	and	CNS	myelinating	glia.	Thereby,	receptors	belonging	to	




Figure	 2:	 Expression	 of	 GPCRs	 during	 oligodendrocyte	 development.	 G-protein	 coupled	 receptors	 are	
known	 to	 regulate	 oligodendrogenesis	 in	 different	 developmental	 stages.	 Ongoing	 research	 revealed	 a	
handful	 GPCRs	 (Gpr17,	 Gpr30,	 S1P1,	 KOR)	 that	 might	 pose	 potential	 therapeutic	 targets	 for	 forcing	
remyelination	when	endogenous	myelination	fails.	Modified	from	(Mogha,	Rozario	and	Monk,	2016).		
For	 instance,	 the	 adhesion	 Gpr56/Adgrg1,	 expressed	 in	 early	 stages	 during	 oligodendrocyte	
development,	 was	 reported	 as	 a	 crucial	 regulator	 of	 OPC	 proliferation	 and	 differentiation.	
Previous	work	in	zebrafish	and	mice	showed	that	depletion	of	Gpr56	produces	hypomyelination	
resulting	from	decreased	OPC	proliferation	(Ackerman	et	al.,	2015;	Giera	et	al.,	2015).	A	further	
study	 in	 mice	 has	 shed	 light	 in	 how	 Gpr37,	 a	 rhodopsin	 family	 GPCR	 affects	 late-stage	
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oligodendrocyte	development.	 Expressed	 and	maintained	 in	mature	oligodendrocytes,	 absence	
of	 Gpr37	 leads	 to	 precocious	 oligodendrocyte	 differentiation,	 entailing	 hypermyelination	 that	
persisted	until	adult	stages	(Yang	et	al.,	2016).	Last	but	not	least,	a	third	GPCR,	Gpr17,	expressed	






Gpr17	 is	 a	 member	 of	 the	 superfamily	 of	 the	 rhodopsin-like,	 seven	 transmembrane	 (7TM)	 G-	
protein	 coupled	 receptors	 (Raport	 et	 al.,	 1996).	 It	 is	 also	 called	 P2Y-like	 receptor,	 since	 it	 is	
phylogenetically	 located	 between	 P2Y	 purinergic	 and	 cysteinyl	 leukotriene	 receptors	 (CysLTRs)	
(Ciana,	Fumagalli,	L.	Trincavelli,	et	al.,	2006).		
1.2.1 Gpr17	localization	
Two	isoforms,	a	 long	form	(Gpr17-L,	369	amino	acids)	that	 is	present	 in	heart	and	kidney	and	a	
short	form	(Gpr17-S,	339	amino	acids)	that	adopts	a	role	in	brain	and	spinal	cord	were	analysed	
by	Benned-Jensen	 and	Rosenkilde	 (2010).	 In	 the	CNS,	 short	 form	Gpr17	 is	mainly	 expressed	 in	
OPCs	and	pre-OLs	and	disappears	when	cells	 achieve	 functional	maturation	 (Chen	et	al.,	 2009)	
(Figure	2).	While	additionally	expressed	 in	ependymal	 cells,	 lining	ventricle	 cavities	 (Marucci	et	
al.,	 2016),	 the	 occurrence	 of	 Gpr17	 in	 neurons	 still	 remains	 controversial	 (Maisel	 et	 al.,	 2007;	
Lecca	et	al.,	2008;	Chen	et	al.,	2009).	Due	to	this	expression	pattern,	Gpr17	 is	assumed	to	be	a	




et	 al.,	 2009;	 Zhao	 et	 al.,	 2012).	 Moreover,	 it	 was	 shown	 that	 experimental	 autoimmune	
encephalomyelitis	 (EAE)	 mouse	 models	 display	 abundance	 of	 Gpr17	 in	 demyelinating	 regions	
(Fumagalli	 et	 al.,	 2015).	 Similar	 observations	 were	 reported	 by	 Ou	 et	 al.	 (2016),	 additionally	











wherefore	 Gpr17	 must	 still	 be	 considered	 as	 orphan.	 Conversely,	 a	 small	 synthetic	 molecule,	
MDL29,951	 (2-carboxy-4,6-dichloro-1H-indole-3-propionic	 acid),	 was	 identified	 as	 a	 selective	
activator	of	Gpr17	in	heterologous	expression	systems	and	primary	oligodendrocytes	(Hennen	et	









loss	 induces	 an	 early	 onset	 of	 oligodendrocyte	 maturation,	 while	 overexpression	 results	 in	
impaired	oligodendrocyte	differentiation	and	myelination	(Chen	et	al.,	2009).	These	results	were	
supported	 by	 further	 studies	with	 primary	 rat	 oligodendrocytes,	 that	 demonstrated	 decreased	
Mbp	 expression	 levels	 upon	 receptor	 activation,	 mainly	 mediated	 through	 the	 Gαi/o	 pathway	
(Simon	et	al.,	2016).	Furthermore,	it	has	been	shown	that	Gpr17	desensitization	leads	to	terminal	
differentiation	 of	 OPCs	 (Daniele	 et	 al.,	 2014).	 However,	 findings	 obtained	 by	 other	 research	
groups	 implicate	 opposing	 results,	 whereby	 Gpr17	 activation	 through	 postulated	 endogenous	
ligands	 resulted	 in	 promoted	 OPC	 maturation	 and	 myelination,	 while	 receptor	 inhibition	 by	
antagonists	 as	 well	 as	 specific	 silencing	 RNAs	 caused	 opposite	 effects	 (Ceruti	 et	 al.,	 2009;	
Fumagalli	 et	 al.,	 2011).	 Contradicting	 their	 own	 findings,	 some	 years	 later,	 the	 same	 research	





In	 scientific	 research,	 cell	 cultures	 or	 tissue	 samples	 are	 extremely	 useful	 in	 providing	 initial	
approaches	 for	 probing	 human	 diseases	 and	 discovering	 new	 human	 drugs.	 However,	 to	
ascertain	 whether	 patient’s	 symptoms	 are	 caused	 by	 genetic	 alternations	 or	 alleviated	 by	
therapeutical	compounds,	the	use	of	in	vivo	model	organisms	is	still	the	gold	standard.	Likewise,	
for	 the	 identification	of	pathways	and	key	molecules	 that	 control	developmental	processes,	 an	
analysis	in	a	native	in	vivo	environment	is	superior	to	in	vitro	systems.		
In	the	field	of	myelination,	rodents	display	the	preferred	animal	models	since	over	90	%	of	their	
genes	 can	be	aligned	with	 the	human	genome	 (Waterston	et	al.,	 2002).	However,	 long	 rearing	
periods	 and	 low-throughput	 evince	 limitations	 of	 this	 model	 organism	 (Cole	 et	 al.,	 2017).	






(Kari,	 Rodeck	 and	 Dicker,	 2007),	 seems	 to	 have	 not	 much	 in	 common	 with	 humans,	 but	 its	
remarkable	genome	homology	over	70%	with	mammals	made	it	a	very	useful	vertebrate	genetic	
model	organism	to	study	key	developmental	processes,	 investigate	human	diseases	or	conduct	
pharmacological	 drug	 screenings	 (Langheinrich,	 2003;	 Howe	 et	 al.,	 2013).	 One	 of	 its	 unique	
advantages	includes	the	short	life	circle	accompanied	by	a	rapid	ex	utero	development	that	can	
be	 perused	 by	 distinct	 non-invasive	 imaging	 methods.	 The	 ability	 to	 follow	 developmental	
processes	 in	 a	 live	 intact	 organism	 is	 further	 supported	 by	 the	 optical	 clarity	 of	 the	 embryos.	
Within	 5	 days,	 a	 zebrafish	 develops	 from	 a	 fertilized	 egg	 to	 a	 fish	 exhibiting	 most	 of	 the	
mammalian	organs	(Figure	3)	(Kari,	Rodeck	and	Dicker,	2007).	The	ability	of	zebrafish	to	produce	
every	 two	 to	 three	 days	 large	 clutch	 sizes	 with	 hundreds	 of	 individuals,	 already	 at	 the	 age	 of	
three	months,	displays	a	feature	that	facilitates	genetic	analysis,	since	research	depends	on	fast	






Figure	 3:	 Development	 of	 zebrafish	 during	 the	 first	 5	 days	 post	 fertilization	 (dpf).	 hpf	 =	 hours	 post	
fertilization.	Modified	from	(Haffter	et	al.,	1996)	
1.3.2 Myelination	and	remyelination	in	zebrafish	
Studies	 with	 zebrafish	 established	 that	 oligodendrocyte	 development	 and	 myelination	 is	
conserved	from	fish	to	mammals	(Raphael	and	Talbot,	2011).	Expression	of	transcription	factors	
such	as	Olig1	and	Olig2,	 Sox10	and	Nkx2.2.	 is	 identical	 across	 species	 (Monk	and	Talbot,	2009;	
Kucenas,	 Snell	 and	 Appel,	 2010)	 and	 although	 there	 is	 some	 variation	 in	 expression	 pattern	
compared	to	mammals,	homologs	for	myelin	proteins	such	as	myelin	basic	protein	(Mbp)	(Nawaz	
















developmental	 and	 myelinating	 processes	 occurs	 earlier	 in	 zebrafish,	 at	 3	 dpf	 (Brösamle	 and	
Halpern,	2002)	compared	 to	mice	exhibiting	myelination	at	P6	 (Foran	and	Peterson,	1992),	 the	
zebrafish	represents	an	ideal	model	to	follow	myelination	in	real-time	in	its	native	environment.	
In	 comparison	 to	mammals,	 zebrafish	exhibit	 the	unique	ability	 to	 regenerate	 injured	axons	by	
continuous	 endogenous	 remyelination	 (Becker	 and	 Becker,	 2008;	 Ohnmacht	 et	 al.,	 2016).	
Goldsmith	et	al.	(2012)	assumed	that	efficient	axon	regeneration	capability	is	likely	to	be	present	
because	 of	 lacking	 glial	 scar	 formation.	 Since	 major	 reasons	 remain	 speculative	 at	 the	 time,	
further	studies	with	zebrafish	may	help	to	elucidate	pathways	or	tractable	key	molecules	that	are	






During	 the	 last	 decades	 a	 wide	 variety	 of	 different	 techniques	 for	 studying	 myelination	 and	
remyelination	in	zebrafish	have	been	created.	One	big	strength	was	the	generation	of	transgenic	




tg(plp:EGFP)	 (Yoshida	 and	 Macklin,	 2005)	 or	 tg(mbp:EGFP)	 (Jung	 et	 al.,	 2009)	 label	
oligodendrocyte	 lineage	 cells	 or	myelin	 sheaths	 and	 provide	 the	 opportunity	 to	 gain	 profound	
insights	in	OPC	generation,	migration	and	myelination	in	the	spinal	cord.	Furthermore,	expression	
of	specific	proteins	can	be	easily	obtained	by	microinjections	of	either	capped	mRNA	or	plasmids	
into	 the	 one-	 or	 two-cell	 stage	 of	 zebrafish	 embryos,	 leading	 to	 an	 expression	 throughout	 the	
whole	 animal,	 unless	 the	 injected	 nucleic	 acids	 contain	 tissue	 specific	 promoters	 (Kari,	 Rodeck	
and	Dicker,	2007).	 In	doing	 so,	 zebrafish	 can	also	be	humanised	with	genes	 involved	 in	human	
diseases	(Goldsmith,	2004).	On	the	contrary,	Zink	Fingers	(Urnov	et	al.,	2010),	TALEN’s	(Campbell	
et	 al.,	 2012)	 or	 more	 current	 CRISPR	 (Blackburn	 et	 al.,	 2013)	 methodologies	 display	 the	
opportunity	to	generate	knockout	zebrafish.	A	timesaving	alternative	to	knockout	animals	offers	
the	 morpholino	 antisense	 oligonucleotides	 mediated	 gene	 knockdown,	 which	 impairs	 the	





drug	 discovery	 (Langheinrich,	 2003;	 Goldsmith,	 2004;	 Kari,	 Rodeck	 and	 Dicker,	 2007).	 As	
producing	 high	 numbers	 of	 offspring,	 they	 provide	 a	 rapid	 and	 low	 cost	 high-throughput	
screening	model.	Drugs	can	be	easily	administered	by	bath	treatment.	From	1	to	3	dpf,	embryos	
are	 able	 to	 absorb	 substances	 across	 the	 skin,	 while	 after	 3	 dpf	 the	 oral	 route	 dominates	
(Goldsmith,	2004).	At	this,	compounds	have	to	overcome	the	blood	brain	barrier	that	allows	the	
transition	of	molecules	smaller	than	1000	kD	(Joeng	et	al.,	2008).	In	case	of	large	molecule	drugs,	
microinjection	 of	 embryos	 display	 an	 alternative	 drug	 administration	 (Goldsmith,	 2004).	 After	
treatment,	 several	 methods	 such	 as	 fluorescent	 and	 electron	 microscopy,	 quantitative	
polymerase	 chain	 reaction	 (qPCR),	 Whole-mount	 in	 situ	 hybridization	 (WISH)	 or	
immunohistochemistry	(IHC)	assays	can	be	performed	to	examine	potential	effects	(Pruvot	et	al.,	
2014;	 Guo	et	 al.,	 2015).	 Until	 now	 a	 few	 chemical-screening	 studies	 have	 been	 published.	 For	
Introduction	
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instance,	 Buckley	 et	 al.	 (2010)	 generated	 a	 robust	 screening	 platform	 and	 identified	 several	
compounds	 with	 pro-myelinating	 features.	 Recently	 it	 has	 been	 shown	 that	 treatment	 of	
zebrafish	 larvae	 with	 the	 antihistaminic	 drug	 clemistine	 rescued	 hypomyelination	 in	 mct8	




Since	 researchers	 discovered	 that	 G-protein	 coupled	 receptors	 intervene	 in	 the	 myelination	
process	(Mogha,	Rozario	and	Monk,	2016),	a	zebrafish	myelination	screen	identified	the	orphan	
Gpr126/Adgrg6	as	a	crucial	 regulator	of	Schwann	cells	differentiation	 in	 the	PNS.	 It	was	 shown	
that	 absence	of	Gpr126	 restrains	 Schwann	 cells	 in	 its	 premyelinating	 stage	 (Monk	et	al.,	 2009,	
2011).	 Meanwhile,	 two	 different	 working	 groups	 postulated	 type	 IV	 collagen	 (Paavola	 et	 al.,	
2014)	as	well	as	Laminin-211	(Petersen	et	al.,	2015)	as	activators	of	Gpr126	by	means	of	zebrafish	
animal	models.	Another	GPCR,	Gpr56,	enriched	in	oligodendrocyte	lineage	cells,	was	found	to	be	
a	 key	 regulator	 of	 oligodendrocyte	 development	 in	 the	 central	 nervous	 system	 (Giera	 et	 al.,	
2015).	Ongoing	studies	 in	zebrafish,	uncovered	Gα12/13-Rho	signalling	as	key	pathway	for	Gpr56	
dependent	 OPC	 proliferation	 (Ackerman	 et	 al.,	 2015).	 These	 studies	 further	 demonstrate	 the	










2013b;	 Schneider	 et	 al.,	 2016;	 Simon	 et	 al.,	 2016;	 Seyedsadr	 and	 Ineichen,	 2017).	 However,	
discrepancies	between	published	 literature	query	Gpr17	agonist	and	antagonist	profiles	as	well	
as	 its	 function	 in	 demyelinating	 pathologies	 (Marucci	 et	 al.,	 2016).	 Thus,	 further	 studies	 are	
necessary	 to	 clarify	 its	 role	 and	 discover	 new	 therapeutic	 compounds	 with	 activity	 on	 human	
Gpr17.	 Herein,	 this	 thesis	 scrutinize	 whether	 the	 zebrafish	 (Danio	 rerio)	 is	 a	 suitable	 animal	
model,	 not	 only	 in	 terms	 to	 confirm	 receptor’s	 role	 in	 myelination	 but	 also	 in	 relation	 of	
presenting	an	 in	vivo	screening	platform	for	new	ligands	of	human	Gpr17	as	modulators	of	CNS	
remyelination.		
The	 first	 element	 of	 this	work	 intends	 to	 verify	 activity	 of	 zebrafish	Gpr17	 upon	 expression	 in	
mammalian	cells	towards	the	postulated	ligands	(Ciana,	Fumagalli,	M.	L.	Trincavelli,	et	al.,	2006),	




embryos	 are	 bath	 exposed	 to	 MDL29,951	 and	 screened	 for	 alterations	 in	 oligodendrocyte	
development	 and	 myelination.	 Additionally,	 chimeric	 receptors	 containing	 the	 ligand	 binding	
domain	 of	 human	 Gpr17	 and	 the	 intracellular	 loops	 of	 zebrafish	 Gpr17	 are	 constructed	 and	
evaluated	in	functional	DMR	assays	as	potential	tools	for	an	in	vivo	zebrafish	screening	platform.	
The	second	part	of	the	thesis	focuses	on	Gpr17	expression	and	role	in	the	zebrafish	itself.	To	this	
end,	 expression	 pattern	 will	 be	 analysed	 by	 Whole-mount	 in	 situ	 hybridization	 (WISH)	 and	

























































Constituent	 Volume	(mL)	 Concentration	(M)	 Final	concentration	(mM)	
NaCl	 60	 2.9	 174	
KCl	 30	 0.07	 2.1	
MgSO4x7H2O	 30	 0.04	 1.2	
Ca(NO3)2	 30	 0.06	 1.8	
HEPES	 30	 0.5	 15	




















Anti-36k	(flj13639)	 rabbit	 QPE0580	 Thermo	Fisher	Scientific	
Anti-β-actin-HRP	 mouse	 A3854	 Sigma-Aldrich	
Anti-ClaudinK	 rabbit	 QPE0581	 Thermo	Fisher	Scientific	
Anti-Cleaved	Caspase3	 rabbit	 9579	 Cell	Signaling	Technology	
Anti-Digoxigenin-AP	 sheep	 11093274910	 Roche	
Anti-EGFP	 mouse	 JL8-632381	 Takara	Clontech	
Anti-HA	 mouse	 11583816001	 Roche	
Anti-MbpA	 guinea	pig	 QOJ1724	 Thermo	Fisher	Scientific	
Anti-P0		 rabbit	 QOJ1722	 Thermo	Fisher	Scientific	
Anti-zfAGpr17	 chicken	 QOJ1726	 Thermo	Fisher	Scientific	






Anti-chicken-HRP	 goat	 ab97150	 Abcam	
Anti-guinea	pig-AlexaFlour546	 goat	 A-11074	 Molecular	Probes	
Anti-mouse-HRP	 goat	 115-035-003	 Jackson	Immuno	Research		
Anti-mouse-HRP	 goat	 A4416	 Sigma-Aldrich	
Anti-rabbit-HRP	 goat	 111-035-144	 Jackson	Immuno	Research		






































































































































































































































































































































































































































































































































































































































in	 room	 atmosphere	 at	 28	 °C.	 To	 prevent	 contamination,	 all	 cell	 culture	 procedures	 were	




The	 immortalized	 cell	 line	 was	 passaged	 two	 times	 a	 week	 and	 used	 for	 experiments	 until	







PAC2	 fibroblast	 cells	 proliferate	 rather	 slowly.	 Hence,	 they	were	 passaged	 every	 10	 days	 after	
reaching	100	%	confluency.	Cells	were	washed	once	a	week	with	15	mL	PBS	and	provided	with	



























Cell	 counting	 was	 conducted	 with	 Neubauer	 counting	 chamber	 that	 contained	 two	 counting	
areas.	Before	loading	10	µL	of	cell	suspension,	a	glass	cover	was	placed	over	the	central	area	of	
the	chamber.	Using	a	microscope,	cells	were	counted	in	four	of	nine	squares	without	taken	those	







Transient	 transfection	 is	 a	 temporary	 non-viral	 delivery	 of	 genetic	 material	 into	 cultured	
eukaryotic	cells.	
The	 non-liposomal	 transfection	with	 FuGENE®	 HD	was	 conducted	 according	 to	manufacturer’s	








for	 achieving	 sufficient	 attachment	 and	 effective	 growth	 of	 cells.	 Cell	 culture	 surfaces	 were	
covered	with	 0.1	mg/mL	 PDL	 solution	 and	 incubated	 for	 1	 h	 in	 a	 37	 °C	 incubator.	 The	 coating	








receptor	 functionality	 in	 living	 cells	 in	 real-time.	 Upon	 application	 of	 stimuli,	 a	 holistic	 cell	
response	 emerging	 as	 a	movement	 of	 biomass	 (mass	 redistribution)	 is	 captured	 by	 a	 resonant	
waveguide	grating	(RWG)	biosensor	(Fang	et	al.,	2007).	Distinct	events	 including	 ligand	binding,	
receptor	activation,	internalization	or	recycling	as	well	as	protein	recruitment	can	be	recorded	by	
this	method.	 The	 readout	 is	 based	on	 changes	of	 the	wavelength	of	 polarized	broadband	 light	
reflected	by	the	biosensor	depending	the	optical	density	of	the	cell	layer	within	150	nm	from	the	
plate	 bottom.	 The	 shifts	 in	 wavelength	 (Δpm)	 are	 recorded	 over	 time	 relative	 to	 the	 baseline	
value.	An	accumulation	of	mass	causes	positive	DMR	responses	(reflection	of	longer	wavelength),	







DMSO	 content	 of	 compound	 dilutions.	 Buffer	 was	 aspirated	 by	 using	 a	 manifold	 and	 a	 final	
volume	of	30	µL	was	added	to	each	well.	The	microplate	was	equilibrated	1	h	at	37	°C	onto	the	
DMR	reader.	In	the	meantime	a	serial	dilution	of	the	compound	was	produced	and	transferred	in	
a	 384-well	 compound	 plate.	 With	 respect	 to	 the	 compound	 dilution	 during	 addition	 to	 the	
biosensor	plate,	compounds	were	prepared	4-fold	concentrated.	The	compound	plate	was	kept	
for	30	min	at	37	°C	in	the	incubator	of	the	semi-automatic	pipetting	system	CyBi®	Selma.	Before	
starting	 the	measurement,	 the	 cell	 plate	was	 aligned	 to	 the	 camera	by	using	 the	Epic®	Aligner	









macro	 and	 finally	 analysed	 with	 GraphPad	 Prism®.	 All	 DMR	 data	 were	 buffer-corrected	 and	
concentration-effect	 curves	 were	 calculated	 based	 on	 maximal	 response	 until	 1800	 s.	








24	 h	 after	 transfection,	 HEK293	 cells	 were	 detached	 and	 seeded	 into	 PDL-coated	 96-well	
microtiter	plates	at	a	density	of	50	kc/well.	Cells	were	cultivated	overnight	at	37	°C	under	5	%	CO2	
conditions.	On	the	day	of	the	assay	(48	h	after	transfection),	cell	medium	was	quickly	aspirated	







by	 adding	 100	 μL/well	 of	 the	 colorimetric	 horseradish	 peroxidase	 substrate	 3,3ʹ,5,5ʹ-
tetramethylbenzidine	 (TMB).	 After	 3-5	min,	 reaction	was	 terminated	with	 50	 µL/well	 of	 0.5	M	
H2SO4.	 130	 µL	 supernatant	 were	 transferred	 into	 a	 new	 96-well	 plate	 with	 clear	 bottom	 and	
colorimetric	readings	were	obtained	using	Tecan	Sunrise	reader	at	450	nm.	
3.2.2.2 Data	determination	





Immunocytochemistry	 (ICC)	 is	 a	 fluorescent	 dye-based	 laboratory	 technique	 that	 uses	 specific	
antibodies	 to	 visualize	 the	 localization	 of	 proteins	 in	 cells.	 In	 this	 case,	 a	 primary	 antibody	
targeted	 against	 the	 N-terminal	 3HA-tag	 of	 GPR17	 constructs	 was	 used	 in	 conjunction	 with	 a	
fluorescent-labelled	secondary	antibody.	
3.2.3.1 Experimental	procedure	






























rpm)	 for	 45	min	 at	 37	 °C.	 Following	 centrifugation	 at	 13,000	 rpm	 for	 1	min,	 supernatant	 was	
discarded	leaving	200	µL	in	the	eppendorf	vial.	Bacteria	were	resuspended	and	plated	onto	pre-
warmed	 LB	 plates	 containing	 100	µg/mL	 ampicillin.	 Plates	were	 incubated	 at	 37	 °C	 and	 clones	
were	picked	after	24	h.	
3.3.3 Cryopreservation	of	bacterial	strains	




Preparative	 isolation	 of	 plasmid	 DNA	 such	 as	 necessary	 for	 transfection	 experiments	 was	
conducted	by	using	NucleoBond®	Xtra	Maxi	Kit.	 To	 this	end,	20	µL	of	 thawed	glycerine	 culture	
were	pipetted	in	300	mL	of	LB	medium	containing	the	respective	antibiotic	and	cultivated	under	

















Protein	 concentration	 was	 determined	 by	 PierceTM
	
BCA	 Protein	 Assay	 Kit	 according	 to	 the	
manufacturer`s	 recommendations.	 The	 detection	 is	 based	 on	 reduction	 of	 Cu2+	 to	 Cu1+	 in	 an	




200	 µL	 of	 fresh	 protein	 detection	 reagent	 were	 added	 to	 each	 sample	 and	 mixtures	 were	
incubated	 for	 30	 min	 at	 37	 °C.	 Finally,	 absorption	 was	 measured	 at	 560	 nm	 using	 the	 Tecan	
Sunrise	reader.	Protein	concentrations	were	computed	based	on	the	BSA	standard	curve.	
3.3.6.3 SDS-Polyacrylamide-Gel-Electrophoresis	(SDS-PAGE)	
After	 determination	 of	 protein	 amount,	 NuPage®	 Sample	 Reducing	 Agent	 (10x)	 and	 NuPage®	
Sample	Buffer	(2-4x)	were	added	to	15	µg	cell	lysate.	Proteins	were	separated	by	their	mass	at	60	
V	for	3	h	in	10	%	NuPage®	Bis-Tris	Protein	Gels.	Gels	were	fixed	in	a	chamber	with	running	buffer,	






blotting	 module.	 Briefly,	 a	 sandwich	 of	 successive	 layers	 of	 prewetted	 sponges,	 filter	 papers,	





added	and	 incubated	at	4	 °C	overnight.	Next	morning,	 the	extent	of	antibody	was	 removed	by	
three	washing	steps,	each	5	min	at	RT.	Membranes	were	 incubated	for	1	h	with	the	respective	
horseradish	 peroxidase-conjugated	 secondary	 antibody	 and	 washed	 again	 three	 times	 with	
washing	 buffer.	 Finally,	 proteins	 were	 detected	 by	 chemiluminescence	 using	 Amersham	 ECL	
Prime	Western	Blotting	Detection	Reagent	according	to	the	manufacturer’s	recommendations.			
3.3.6.6 Data	determination	
Quantification	was	achieved	by	 scanning	 the	blot	with	an	 imager	and	densitometric	analysis	of	
bands	using	Gel	scan	software.	To	account	for	possible	loading	as	well	as	transfer	errors,	samples	






Zebrafish	 lines	 were	maintained	 at	 28	 °C	 in	 the	 Zebrafish	 facility	 of	 the	 Institute	 of	 Anatomy,	
University	of	Bonn	according	to	previously	described	standard	protocols	(Westerfield,	2007).		
Embryos	were	collected	from	mating	pairs	and	reared	at	28.5	°C	in	30	%	Danieau	egg	water	(17.4	
mM	 NaCl,	 0.21	 mM	 KCl,	 0.12	 mM	MgSO4,	 0.18	 mM	 CaCl2,	 1.5	 mM	 HEPES)	 containing	 10-5	 %	
methylene	blue	for	the	first	24	h.	To	inhibit	pigmentation	of	embryos	older	than	1	dpf,	egg	water	





The	 antisense	 zfAgpr17	 morpholino	 (MO)	 5’GTTCTHTCAAGGAGGACTCCATTT3’	 and	 a	 control	
morpholino	 5’	 CCTCTTACCTCAGTTACAATTTATA3’	 were	 purchased	 as	 lyophilized	 stocks	 from	





zfAgpr17	 MO.	 Once	 the	 parameters	 were	 adjusted,	 embryos	 at	 one-	 or	 two-cell	 stage	 were	
placed	in	an	injection	mold	and	injected	into	the	yolk.	






𝑉!"#$%&!!" =  43  × 𝜋 ×  135 µ𝑚2 ! = 12288249 µ𝑚!	1 µ𝑚!  =  1 × 10!! µ𝐿	
12288249 µ𝑚! × 1 10!! µ𝐿µ𝑚! = 0,0013 µ𝐿 =  1,3 𝑛𝐿	
𝑛 =  𝑐 × 𝑉 =  0,25 × 10!!  𝑚𝑜𝑙𝐿 × 1,3 × 10!! 𝐿 = 3,25 ×10!!" 𝑚𝑜𝑙	






linearized	 with	 XhoI	 and	 transcribed	 as	 mentioned	 in	 the	 protocol.	 Linearization	 of	 control	

















Before	 treatment	was	 applied,	 1	 dpf	 embryos	were	 enzymatically	 removed	 from	 their	 chorion	
with	 2	mg/mL	pronase	 in	 30	%	Danieau.	 10	mM	MDL29,951/DMSO	 stock	 solution	was	 diluted	
with	30	mL	30	%	Danieau	containing	0.003	%	PTU	to	10	and	30	µM	working	solution.	0.1	%	and	
0.3	%	DMSO	were	used	as	controls.	Larvae	were	exposed	to	the	compound	for	5	days	in	a	light	
cycle	 incubator	 at	 28.5	 °C.	 The	 treatment	 solution	was	 renewed	 every	 24	 h.	 Therefore	 1.5	mL	
solution	with	all	embryos	were	transferred	 in	an	Eppendorf	 tube	and	28.5	mL	of	 fresh	Danieau	
solution	 containing	 MDL29,951	 were	 poured	 in	 a	 new	 petri	 dish.	 Finally	 1.5	 mL	 of	 zebrafish	
embryos	 were	 added	 to	 the	 renewed	 drug	 solution.	 At	 5	 dpf	 zebrafish	 were	 imaged	 like	
described	in	chapter	3.7.1	or	collected	for	qPCR	and	Western	blot	analysis.	
3.6.2 TSA	treatment	





microscope	TriMScope	 (LaVision,	BioTec,	Bielefeld,	Germany).	 Spinal	 cord	 segments	4–10	were	
imaged	with	a	20x	water-immersion	objective	lens	(NA	1.0,	W	Plan-Apochromat,	Zeiss®)	directing	









embryos	were	 incubated	with	2	mg/mL	pronase	 in	30	%	Danieau	 for	5-10	min	at	28	 °C.	Larvae	
were	 mounted	 laterally	 in	 1.25	 %	 low	 melting	 agarose	 containing	 5	 %	 MS222	 for	 preventing	
movement	during	the	imaging	procedure.	
3.7.1.2 Analysis	
Analysis	 of	 the	 images	was	 performed	 blindly	 by	 using	 Image	 J®.	 Cells	 were	 counted	 in	 single	
stacks	 and	 numbers	 were	 transferred	 to	 GraphPad	 Prism®.	 For	 all	 experiments	 D’Agostino-




The	EnSightTM	 is	a	 label-free,	well	 imaging	multimode	reader	that	was	used	for	high-throughput	
imaging	and	analysis	of	fluorescent	zebrafish.	The	master	student	Enrico	Mingardo	established	a	
protocol	as	an	alternative	 for	 the	 time	consuming	 screening	with	Two-photon	microscopy.	The	
fluorescent	excitation	measurements	were	performed	at	465	nm	with	an	exposure	time	of	50	ms.	
To	visualized	the	entire	animal,	each	well	was	imaged	as	a	stack	of	six	distinct	focus	channels	with	
a	 height	 of	 25	 µm.	 Images	 were	 analysed	 using	 a	 semi-automatic	 counting	 plugin	 installed	 in	
ImageJ®.	 For	 more	 detailed	 information	 refer	 to	 the	 master	 thesis	 of	 Enrico	 Mingardo	 titled	










The	Whole-mount	 in	 situ	 hybridization	 (WISH)	 protocol	 used	 in	 this	 thesis	 was	 adapted	 from	
Thisse	Lab	–	In	situ	hybridization	Protocol	–	Update	2010	(Thisse	and	Thisse,	2008).	The	principle	
is	based	on	the	complementary	hybridization	of	digoxigenin-labelled	RNA	to	the	specific	RNA	of	
interest.	 Subsequently,	 an	 alkaline	 phosphatase-conjugated	 antibody	 binds	 to	 digoxigenin	 and	
finally	converts	the	colourless	NBT/BCIP	compound	by	removing	phosphate	into	a	purple	dye.	
3.7.3.1 RNA	preparation	
For	 RNA	 transcription,	 plasmids	 including	 T7/T3/SP6	 promoters	 were	 linearized	 with	
corresponding	enzymes	(Table	21)	at	37	°C	overnight.	The	next	day,	templates	were	separated	in	
a	1	%	agarose	gel	and	extracted	from	the	gel	by	using	the	NucleoSpin	Gel	and	PCR	Clean-UP	Kit.	











nkx2.2	in	pBlueSkriptII	SK		 antisense	 SacII,	XbaI	 T7	
	 sense	 XhoI,	KpnI-HF	 T3	
zfAGpr17	in	pBlueSkript	II	SK	 antisense	 HindII,	EcoRI	 T7	





















After	 24	 hpf,	 30	 %	 Danieau	 fish	 water	 should	 include	 PTU,	 since	 pigmentation	 needs	 to	 be	
prevented	 for	 WISH.	 Larvae	 younger	 than	 3	 dpf	 were	 removed	 from	 their	 chorions	 by	 using	
pronase	 enzyme	 like	 described	 in	 chapter	 3.6.1.	 In	 brief,	 larvae	 were	 fixed	 with	 4	 %	
paraformaldehyde	in	PBS	at	4	°C	overnight	and	dehydrated	the	next	day	in	a	series	of	25	%,	50	%	




for	 10	min.	 For	 permeabilization,	 zebrafish	 embryos	 were	 digested	 with	 proteinase	 K	 in	 PBST	
















however	 for	 20	 min	 instead	 of	 10	 min.	 Subsequently,	 three	 longer	 washing	 steps	 followed,	
including	 30	 min	 with	 0.2x	 SSC	 and	 two	 times	 30	 min	 with	 0.1x	 SSC	 at	 70	 °C.	 All	 room	
temperature	washing	steps	were	conducted	with	0.1x	SSC	diluted	in	the	described	concentration	
with	PBST.	After	blocking	 for	2-3	h	with	2	mg/mL	BSA	 /2	%	Sheep	 serum/	PBST,	 samples	were	
exposed	 to	 the	 anti-DIG	 antibody	 (1:20,000)	 at	 4	 °C	 overnight.	 Next	 morning	 embryos	 were	
washed	with	 PBST	 and	 pre-incubated	 in	 alkaline	 tris	 buffer	 (Solution	 13)	 like	 described	 in	 the	
protocol.	 Afterwards,	 alkaline	 tris	 buffer	 was	 replaced	 by	 700	 µL	 labelling	 solution	 including	
NBT/BCIP	(Solution	14).	Once	the	desired	staining	intensity	was	reached,	1	mM	EDTA	(pH	5.5)	in	
PBS	was	used	 to	 stop	 the	 labelling	 reaction.	 For	 reducing	 the	background,	3	dehydration	 steps	
with	25	%	and	two	times	with	50	%	methanol	 in	PBST	 followed.	Samples	were	kept	 for	several	









The	 combination	 of	 a	 reverse	 transcription	 (RT)	 followed	 by	 a	 quantitative	 polymerase	 chain	
reaction	 (qPCR)	 is	 a	 powerful	 tool	 to	 quantify	 the	 expression	 of	 genes	 (Livak	 and	 Schmittgen,	
2001).	 In	 this	 thesis,	 gene-specific	 fluorescent	 probes	 including	 a	 reporter	 dye	 at	 the	 5’	 and	 a	
quencher	at	the	3’	were	used	for	the	quantitative	detection	of	the	amplicons.	The	probe	binding	






were	 transferred	 to	 Precellys	 tubes	 filled	 with	 beads	 and	 homogenized	 with	 the	 Precellys	 24	
setting	5000-1x10-005.	 Following	homogenization,	 supernatants	were	pipetted	 into	RNase-free	
tubes	and	centrifuged	at	12,000	x	g	for	10	min	at	4	°C.	Subsequently,	samples	were	incubated	for	
5	min	at	RT,	mixed	with	0.2	mL	chloroform	and	vortexed	for	15	s.	After	incubation	of	2-3	min	at	
RT	a	centrifugation	at	12,000	x	g	 for	15	min	at	4	 °C	 followed.	The	upper	aqueous	phases	were	
placed	 into	 new	 RNAse-free	 tubes	 and	 supplemented	 with	 100	 %	 isopropanol.	 After	 briefly	
vortexing,	samples	were	incubated	again	for	10	min	at	RT	and	centrifuged	again	at	12,000	x	g	for	













































min	 with	 PBST.	 To	 break	methylene	 bridges	 formed	 during	 the	 fixation,	 heat-induced	 epitope	
retrieval	was	performed	with	150	mM	Tris	buffer	 (Solution	15)	 for	5	min	at	RT,	 followed	by	an	
incubation	with	 exchanged	 solution	 for	 15	min	 at	 70	 °C	 in	 the	water	 bath.	 After	 two	washing	
steps	with	 PBST	 for	 5	min,	 4	 dpf	 embryos	were	 permeabilized	with	 10	mg/mL	 proteinase	 K	 in	
PBST	for	90	min	at	RT.	Digestion	was	stopped	with	4	%	paraformaldehyde	for	20	min	at	RT.	For	
the	entire	removal	of	the	fixation	solution,	embryos	were	washed	five	times	for	5	min	with	PBST	
and	 subsequently	 blocked	with	NGS/BSA/PBTx	 blocking	 solution	 	 (Solution	 18)	 for	 4	 h	 at	 4	 °C.	


















Immunohistochemistry	 analysis	 (IHC)	 of	 zebrafish	 spinal	 cord	 sections	 were	 conducted	 by	 Dr.	
Anna	 Sophia	 Japp	 (Institute	 of	 Neuropathology,	 Medical	 Centre,	 University	 of	 Bonn).	 3	 dpf	
zebrafish	 were	 fixed	 in	 4	 %	 formalin	 and	 stored	 at	 4	 °C.	 All	 experiments	 were	 performed	 on	
Ventana	Benchmark	XT	Immunostainer	(Roche	Ventana,	Darmstadt,	Germany)	with	the	antibody	







To	analyze	protein	expression,	 20	 zebrafish	embryos	were	 collected	 in	 a	pre-cooled	Eppendorf	
tube.	 After	 anaesthetization	 on	 ice	 for	 5	 min	 and	 entire	 removal	 of	 water,	 zebrafish	 were	





Protein	 concentration	was	 analyzed	 by	 the	 Bradford	 dye	 assay	 that	 is	 based	 on	 a	 colorimetric	





















The	 vacuum	was	 applied	 until	 the	 frame	 was	 completely	 empty.	 Next,	 7	 mL	 of	 first	 antibody	
diluted	 in	 blocking	 solution	 were	 added	 to	 the	 blot	 holder	 frame	 and	 incubated	 for	 10	 min.		
Membranes	were	washed	 three	 times	with	30	mL	washing	buffer	 (TBST	0.01	%)	and	 incubated	
again	 with	 10	 mL	 of	 the	 respective	 horseradish	 peroxidase-conjugated	 secondary	 antibody	
diluted	 in	 blocking	 buffer.	 After	 three	 additional	 washing	 steps	 with	 30	 mL	 washing	 buffer,	









The	 first	 chapter	 will	 explore	 receptor	 functionality	 of	 zebrafish	 Gpr17	 in	mammalian	 HEK293	





ligands	 of	 the	 G-protein	 coupled	 receptor	 17	 (Ciana,	 Fumagalli,	M.	 L.	 Trincavelli,	 et	 al.,	 2006).	
However,	several	independent	laboratories	failed	to	confirm	the	deorphaning	report	(Heise	et	al.,	





exposed	 to	 the	 purported	 endogenous	 agonists	 and	 receptor	 mediated	 cell-responses	 were	
monitored	by	holistic	DMR	assays.	None	of	the	ligands	displayed	any	sign	of	activity	at	all	applied	
concentrations	 (Figure	 5).	 Loss	 of	 cell	 viability	 as	 reason	 for	 the	 missing	 response	 can	 be	
excluded,	 since	 carbachol	 and	ATP	 elicited	 robust	DMR	 signals	 in	HEK293	 cells	 upon	 acting	 on	
endogenously	expressed	muscarinic	M3	and	adenosine	A1	receptors.	
These	 data	 demonstrate	 that	 zfAGpr17	 is	 completely	 inert	 towards	 uracil	 nucleotides	 and	





Figure	 5:	 Zebrafish	 Gpr17	 version	 A	 is	 unresponsive	 towards	 uracil	 nucleotides	 and	 cysteinyl	
leukotrienes.	HEK293	cells	transiently	transfected	with	zfAGpr17	revealed	no	receptor	specific	 functional	
activity	 after	 stimulation	 with	 putative	 endogenous	 ligands	 (LTC4,	 LTD4,	 UDP,	 UDP-gal,	 UDP-glc)	 (A-E).	
Signatures	 are	 representative	 traces	 (means	 +	 SEM)	 from	 at	 least	 three	 independent	 experiments,	 each	
performed	 in	 triplicates.	 Concentration-effect	 curves	 (F)	 were	 generated	 by	 calculation	 of	 the	 maximal	
response	within	1800	s	(means	±	SEM).		
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carboxy-4,6-dichloro-1H-indole-3-propionic	 acid),	 has	 been	 identified	 in	 previous	 studies	 as	 a	
selective	agonist	 for	human	and	rodent	Gpr17	(Hennen	et	al.,	2013b).	Further	studies	reported	
that	 Oli-neu	 cells	 and	 primary	 rat	 oligodendrocytes,	 which	 endogenously	 express	 Gpr17,	
displayed	decreased	myelin	 expression	 upon	 stimulation	with	MDL29,951	 (Simon	et	 al.,	 2016).	
Hence,	in	search	to	find	a	compound	serving	as	a	tool	to	study	receptor	functionality	and	role	of	
zebrafish	 Gpr17	 in	 vivo,	 whole-cell	 activity	 of	 zebrafish	 Gpr17	 towards	 MDL29,951	 was	
determined	by	DMR	assays.		
3HA-tagged	 zebrafish	Gpr17	version	A	 (zfA)	and	B	 (zfB),	 transiently	 transfected	 in	HEK293	cells	
were	 seeded	 in	 DMR	 plates	 and	 treated	 with	 increasing	 concentrations	 of	 the	 agonist.	 Cells	
transfected	 with	 empty	 pcDNA3.1	 vector	 remained	 unaffected	 towards	 MDL29,951,	 which	
indicates	 that	 the	 agonist	 did	 not	 evoke	 unspecific	 background	 responses	 (Figure	 6,	 A).	 As	
expected,	MDL29,951	led	to	robust,	concentration-dependent	traces	on	HEK293	cells	expressing	
human	 Gpr17	 (Figure	 6,	 B,	 E),	 thereby	 reaffirming	 the	 functionality	 on	 this	 species.	 However,	
MDL29,951	even	in	the	highest	concentration,	displayed	no	functional	activity	on	zfA	(Figure	6,	C,	
E)	and	zfBGpr17	(Figure	6,	D,	E).		
Together,	 these	data	demonstrate	 that	zebrafish	Gpr17	was	neither	sensitive	 to	 the	postulated	








cells	 transiently	 transfected	 with	 3HA-tagged	 zebrafish	 Gpr17	 versions	 A	 (C)	 and	 B	 (D)	 showed	 no	
responses	 towards	 MDL29,951,	 while	 human	 3HA-Gpr17	 (B)	 displayed	 robust	 concentration-dependent	
signals	 after	 stimulation	 with	 agonist.	 Label-free	 recordings	 are	 shown	 as	 representative	 traces,	 each	
performed	in	triplicates	(means	+	SEM)	(E).	Concentration	response	curves	were	quantified	by	calculation	




To	 account	 for	 potential	 discrepancies	 in	 subcellular	 localisation	 of	 the	 orthologous	 receptors,	
cell	 surface	 expression	 of	 3HA-tagged	 Gpr17	 constructs	 was	 analysed	 by	 fluorescent	
Immunocytochemistry	(ICC).	Thereby,	80,000	HEK293	cells	seeded	on	coverslips	were	imaged	48	
h	 post	 transfection.	 The	 data	 revealed	 equivalent	 membrane	 expression	 within	 all	 constructs	
(Figure	 7,	 B,	 C,	 D),	 while	 control	 transfection	 with	 pcDNA3.1	 displayed	 no	 fluorescence	 at	 all	
(Figure	7,	A).	Accumulation	of	receptors	in	the	cytosol	was	comparable.		
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Figure	 7:	 Immunocytochemical	 localisation	 of	 3HA-tagged	 Gpr17	 constructs	 reveals	 no	 difference.	
Representative	images	of	HEK293	cells,	transiently	transfected	with	human	(B)	and	zebrafish	Gpr17	(C,	D),	
were	obtained	48	h	after	transfection.	Cells	were	treated	with	an	antibody	directed	against	the	N-terminal	
3HA-Tag	 of	 Gpr17	 constructs	 and	 then	 incubated	 with	 a	 Cy2-conjugated	 goat	 anti-mouse	 antibody.	 No	
specific	fluorescence	was	detected	in	empty	vector	control	transfected	HEK293	cells	(A).	Experiments	were	
conducted	at	least	three	times.		
To	 further	 quantify	 expression	 levels,	 Enzyme-linked	 immunosorbent	 assays	 (ELISA)	 were	
performed.	Empty	HEK293	cells	as	well	as	HEK293	cells	transiently	expressing	3HA-tagged	Gpr17	
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Figure	 8:	 Quantification	 of	 cell	 surface	 expression	 of	 Gpr17	 constructs	 displays	 almost	 equivalent	
expression	levels	in	HEK293	cells.	48	h	after	transient	transfection,	cell	surface	expression	of	3HA-tagged	
Gpr17	constructs	was	determined	by	ELISA.	3HA-epitope	allowed	a	comparable	quantification	of	protein	
expression	 in	 the	 cell	 membrane.	 Shown	 are	 representative	 data	 (means	 +	 SEM)	 of	 at	 least	 three	
independent	experiments.	
4.1.4 No	expression	of	zebrafish	Gpr17	in	fibroblast	zebrafish	cell	line	
There	 are	 several	 publications	 studying	 zebrafish	 receptors	 in	 mammalian	 cell	 lines,	 however	
some	 of	 them	 claim	 about	 discrepancies	 in	 functional	 assays	 due	 to	 the	 distinct	 cellular	
background	 (Ringvall,	 Berglund	 and	 Larhammar,	 1997;	 Starback	 et	 al.,	 1999).	 To	 this	 end,	 a	
fibroblast	zebrafish	(PAC2)	cell	line,	kindly	provided	by	Prof.	Dr.	Foulkes	of	Karlsruhe	Institute	of	
Technology	(KIT),	was	transiently	transfected	with	human	and	zebrafish	Gpr17	to	be	analysed	in	







































Figure	9:	MDL29,951	does	not	elicit	Gpr17	 specific	DMR	responses	 in	 zebrafish	PAC2	cells.	 The	agonist	
was	 applied	 in	 increasing	 concentrations	 to	 PAC2	 cells	 that	were	 either	 untransfected	 (A)	 or	 transiently	
transfected	 (FuGENE)	with	human	 (B)	 and	 zfA	 (C)	Gpr17.	 FCS	 control	 signals	were	not	 influenced	by	 the	
absence	 or	 the	 presence	 of	 Gpr17	 receptors.	 DMR	 responses	 were	 recorded	 for	 3600	 s.	 Shown	 are	
representative	traces	(means	+	SEM)	of	three	independent	experiments.	
Given	 this	pattern,	 cell	 surface	expression	was	determined	by	ELISA	assay.	 PAC2	 cells	 revealed	
deficient	 expression	 of	Gpr17	 receptors	 on	 the	 cell	membrane	 similar	 to	 empty	 vector	 control	
transfected	 cells	 (Figure	10).	 Thus,	 the	 lacking	DMR	 response	arose	 from	absentee	 cell	 surface	
expression	 of	Gpr17	 receptors.	 Therefore, the	 need	 of	 a	 fish	 cellular	 background	 for	 sufficient	
signalling	of	zebrafish	Gpr17	cannot	be	concluded	from	this	experiment.	
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Figure	10:	ELISA	 results	display	absent	 cell	 surface	expression	of	orthologous	Gpr17	 receptors	 in	PAC2	
cells.	 Cell	 surface	 expression	 was	 measured	 with	 ELISA	 in	 fibroblast	 zebrafish	 cells	 and	 HEK293	 cells	
transiently	transfected	(FuGENE)	with	6	µg	of	3HA-tagged	Gpr17	receptors.	Cells	were	seeded	in	a	96-well	





and	 investigation	 in	 a	 zebrafish	 cell	 line	 proved	 to	 be	 complicated,	 the	 zebrafish	 itself	 was	





become	 increasingly	popular	during	 the	 last	decades	 (Preston	and	Macklin,	 2015).	 In	 search	of	
potential	 compounds,	 Buckley	 et	 al.	 developed	 a	 screening	 method	 by	 counting	 migrating	
oligodendrocyte	 lineage	 cells	 in	 the	 dorsal	 region	 of	 the	 CNS	 of	 transgenic	 zebrafish	 embryos	
after	bathing	exposure.	Drugs	that	significantly	changed	cell	numbers	were	further	 investigated	
by	 quantitative	 Polymerase	 chain	 reaction	 (qPCR),	 revealing	 direct	 effects	 on	 myelination	
(Buckley	et	al.,	 2010).	Hence,	 tg(claudink:EGFP)	 zebrafish	embryos	were	bath	exposed	 for	96	h	
with	10	µM	MDL29,951	and	total	number	of	claudin	K	positive	cells	were	analyzed	at	5	dpf.	Since	
Claudin	 K	 is	 a	 myelin-associated	 protein,	 expressed	 in	 mature	 myelinating	 oligodendrocytes	

























should	 be	 recognized	 by	 imaging	 this	 transgenic	 zebrafish	 line.	 No	 difference	 in	 numbers	 of	












drug	 treatment	 directly	 affects	myelination.	 To	 this	 end,	mbp	 and	plp	 transcript	 levels	 of	 drug	
exposed	and	control	embryos	were	examined	by	qPCR.	Since	cell	number	was	not	altered	with	10	
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Figure	 12:	 Mbp	 and	 plp	 expression	 levels	 of	 5	 dpf	 old	 zebrafish	 embryos	 are	 not	 influenced	 after	
MDL29,951	treatment.	1	dpf	zebrafish	larvae	were	treated	for	96	h	with	MDL29,951	and	analysed	at	5	dpf	
by	qPCR.	Drug	treatment	with	10	and	30	µM	MDL29,951	did	not	significantly	alter	mbp	and	plp	expression	




To	 further	 verify	 preceding	data,	which	 assumed	 that	 drug	 treatment	with	MDL29,951	did	 not	
affect	myelination	 in	 vivo,	Western	blot	analysis	were	performed	 to	quantify	 the	expression	of	
36k,	 a	 short-chain	 dehydrogenase	 that	 is	 expressed	 in	 oligodendrocytes	 as	 well	 as	 in	 myelin	
sheaths	 in	 the	 CNS	 of	 teleosts	 (Morris	 et	 al.,	 2004).	 In	 congruence	 with	 the	 qPCR	 results,	
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Figure	 13:	MDL29,951	 bath	 exposure	 does	 not	 affect	 expression	 of	 36k	myelin	 protein.	 Western	 blot	
analysis	of	MDL29,951	 treated	zebrafish	 larvae	 revealed	no	difference	 in	expression	of	36k	compared	 to	
control	 treated	 embryos	 at	 5	 dpf.	 Adult	 zebrafish	 brain	 served	 as	 a	 positive	 control.	 Shown	 are	
densitometric	 analysis	 of	 36k	 immunoreactive	 bands,	 quantified	 means	 (+	 SEM)	 from	 five	 independent	
experiments	(A).	(B)	depicts	a	representative	Western	blot.	
Taken	 together,	 these	 results	 indicate	 that	 MDL29,951	 treatment	 does	 not	 modulate	
developmental	myelinating	processes	in	zebrafish,	neither	by	altering	migration	or	differentiation	
of	oligodendrocyte	 lineage	cells	nor	by	directly	effecting	myelin	gene	expression.	Furthermore, 
this	 correlates	 with	 the	 in	 vitro	 results	 generated	 in	 HEK293	 cells,	 where	 the	 activation	 of	
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a	 consequence	 of	 impaired	 ligand	 binding.	 To	 address	 this,	 chimeric	 GPCRs	 containing	 the	
extracellular	domains	and	transmembrane	regions	of	the	human	Gpr17	and	intracellular	loops	of	
the	zebrafish	receptors	(h+zfA;	h+zfBGpr17)	were	constructed	(Figure	14).	Additionally,	chimeric	




Figure	 14:	 Schematic	 prediction	 of	 chimeric	 h+zfAGpr17	 receptor	 topology	 in	 the	 cell	 membrane.	
Chimeric	receptors	were	constructed	by	replacing	the	intracellular	loops	of	the	human	Gpr17	(black)	by	the	
loops	 of	 the	 zebrafish	 Gpr17	 receptors	 (cyan).	 Shown	 is	 a	 representative	 prediction	 schematic	 of	









Thus	 far,	 it	 was	 examined	 that	 the	 native	 zebrafish	 Gpr17	 receptors	 were	 expressed	 in	 the	
membrane	 of	 HEK293	 cells,	 although	 no	 functionality	was	 observed	 after	 stimulation	with	 the	
agonist	MDL29,951.	To	validate	 if	 the	HA-tagged	chimeric	 receptors	were	equally	expressed	on	
the	cell	surface,	ICC	analysis	with	an	antibody	directed	against	the	3HA-epitope	was	performed.	
The	 obtained	 data	 revealed	 that	 all	 four	 chimeric	 receptors,	 transiently	 transfected	 in	 HEK293	
cells,	were	located	in	the	cell	surface	membrane	(Figure	15,	B,	C,	E,	F).		
	
Figure	 15:	 Chimeric	 Gpr17	 receptors	 are	 expressed	 in	 the	 cell	 surface	 membrane	 of	 transiently	
transfected	 HEK293	 cells.	 HEK293	 cells,	 transiently	 transfected	with	 the	 four	 chimeric	 Gpr17	 receptors,	
revealed	 receptor	 localisation	 on	 the	 cell	 membrane	 (B,	 C,	 E,	 F).	 Receptors	 were	 marked	 by	 their	 N-
terminal	3HA-Tag,	48	h	after	transfection.	A	secondary	Cy2-conjugated	goat	anti-mouse	antibody	finally	led	
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orthologous.	 HEK293	 cells	 transiently	 expressing	 3HA-tagged	 Gpr17	 constructs	 were	 investigated	 48	 h	
after	 transfection	 by	 ELISA	 assays.	 Attenuated	 cell	 surface	 expression	 levels	 of	 chimeric	 constructs	





membrane.	 To	 investigate	 whether	 these	 receptors	 are	 functional,	 transiently	 transfected	
HEK293	cells	were	examined	by	DMR	assays.	Cell	lines	expressing	human	Gpr17	with	intracellular	
loops	 of	 zfA	 (Figure	 17,	 A)	 or	 zfBGpr17	 (Figure	 17,	 B)	 generated	 label-free	 responses	 to	
MDL29,951	 in	 a	 concentration-dependent	 manner,	 although	 the	 responses	 were	 diminished	
compared	to	human	Gpr17	(Figure	17,	C,	F).	To	the	contrary,	zfA	(Figure	17,	D)	and	zfB	(Figure	
17,	 E)	 Gpr17	 containing	 intracellular	 loops	 of	 human	 Gpr17	 remained	 unresponsive	 to	 the	


































Gpr17.	 48	 h	 after	 transfection	 of	 HEK293	 cells,	 functional	 analysis	 of	 chimeric	 Gpr17	 receptors	 was	




Taken	 together,	 these	 observations	 lead	 to	 the	 assumption	 that	 MDL29,951	 did	 not	 activate	
zebrafish	Gpr17	 receptors	both	 in	vitro	 and	 in	vivo	 analysis.	Given	 the	 functionality	of	 chimeric	
receptors	 containing	 the	 human	 agonist	 binding	 side,	 it	 becomes	more	 evident	 that	 impaired	
ligand	binding	provoked	the	lack	of	activity	at	the	fish	receptors.		
Moreover,	 the	data	displayed	that	 the	h+zfA	and	h+zfB	chimeric	Gpr17	receptors	 retained	wild	
type	characteristic,	even	though	functionality	was	attenuated.	Since	MDL29,951	did	not	induced	
effects	in	vivo,	it	might	be	possible	that	MDL29,951	treatment	on	zebrafish	transiently	expressing	
the	 chimeric	 Gpr17	 receptors	 causes	 alterations	 in	 myelination.	 If	 this	 proves	 to	 be	 true,	 the	
chimeric	receptors	could	represent	new	valuable	tools	for	screening	of	compounds	with	activity	
on	human	Gpr17	 that	promote	 remyelination	 in	humans.	But	 first	as	a	matter	of	principle,	 the	
role	of	zebrafish	Gpr17	in	vivo	has	to	be	examined.	
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Previously	 published	 data	 indicate	 that	 Gpr17	 is	 abundant	 in	 pre-oligodendrocytes	 (pre-OLs)	
during	 mouse	 CNS	 development,	 but	 not	 detectable	 in	 mature	 oligodendrocytes	 (Chen	 et	 al.,	
2009).	 Since	 the	 zebrafish	 represent	 an	 ideal	 model	 system	 to	 study	 oligodendrocyte	
development	 and	 myelination	 in	 vivo	 (Preston	 and	 Macklin,	 2015),	 gpr17	 RNA	 expression	 in	
zebrafish	embryos	was	determined	by	Whole-mount	in	situ	hybridization	(WISH).		



















To	 prove	 Gpr17	 localisation	 in	 oligodendrocyte	 lineage	 cells,	 zebrafish	 were	 treated	 with	






























zebrafish	 larvae	displayed	 significantly	diminished	gpr17	 expression	 (C)	 in	 the	dorsal	 region	of	 the	 spinal	
cord	after	treatment	with	TSA	(A),	while	control	animals	(B)	depicted	normal	localization	in	both	dorsal	and	




cells,	 expression	 of	 Gpr17	 protein	 was	 analysed	 by	 Western	 blot	 analysis.	 To	 this	 end,	 equal	
amounts	of	total	protein	lysates	were	isolated	from	entire	embryos	at	different	ages.	Throughout	
the	 time	 course,	 immunoreactive	 bands	 at	 sizes	 around	 40	 kDa	 were	 detected	 in	 samples	
harvested	 as	 early	 as	 3	 dpf.	 After	 72	 hpf,	 zfAGpr17	 levels	 increased	 until	 10	 dpf,	 however	 the	








































Figure	20:	 ZfAGpr17	 is	 expressed	during	oligodendrocyte	development.	Western	blot	 analysis	of	Gpr17	
expression	in	zebrafish	larvae,	harvested	at	different	time	points	displayed	protein	expression	from	3	to	10	
dpf	 (A),	 while	 protein	 was	 absent	 in	 adult	 brain	 (B).	 Shown	 are	 representative	Western	 blots	 of	 three	
independent	experiments.		
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Given	 the	 expression	 pattern	 of	gpr17	 in	 the	 developing	 CNS	 of	 zebrafish,	 the	 question	 arose	
whether	 Gpr17	 may	 influence	 oligodendrocyte	 development.	 To	 this	 end,	 transient	




Since	 oligodendrogenesis	 in	 zebrafish	 is	 accompanied	 by	 coordinated	 expression	 of	 distinct	
transcription	 factors	 and	 proteins	 (Kirby	 et	 al.,	 2006;	 Monk	 and	 Talbot,	 2009;	 Münzel	 et	 al.,	




To	 identify	 the	 suitable	 RNA	 concentration	 for	 transient	 OE	 experiments,	 mortality	 rates	 and	
phenotypes	of	 tg(olig2:EGFP)	 zebrafish	embryos,	 injected	with	 increasing	 concentrations	of	 zfA	
and	zfBgpr17	were	determined.	Since	preceding	experiments	displayed	abundances	of	gpr17	 in	
dorsally	migrating OPCs,	 numbers	 of	 olig2	 positive	 cells,	 which	 correspond	 to	 oligodendroglial	
cells	 expressing	 the	 transcription	 factor	 olig2,	 were	 counted	 in	 a	 representative	 region	 of	 the	






Two-photon	microscopy.	 For	overexpression	 and	 knockdown	 studies,	 cell	 numbers	were	 counted	 in	 the	
depicted	dorsal	CNS	region	of	the	spinal	cord	that	encompassed	6	segments.	
Microinjections	 of	 increasing	 amounts	 of	 gpr17	 RNA	 in	 tg(olig2:EGFP)	 zebrafish	 exhibited	
enhanced	mortality	and	varied	phenotypes	 (Figure	22,	A-E).	Especially,	 injections	of	1000	pg	of	


















RNA.	 3	 dpf	 old	 zebrafish	 embryos,	 injected	 in	 the	 one-cell	 stage	 with	 increasing	 RNA	 concentrations	




values	 (±	 SEM);	 each	 concentration	 presents	 one	 experiment.	 One-way	 ANOVA	was	 used	 for	 statistical	
significance.	*,	P<0.05.	
In	 order	 to	 verify	 the	 success	 of	 RNA	expression,	 zebrafish	 embryos	were	 additionally	 injected	
with	tdTomato.	The	red	fluorescent	protein	was	expressed	even	 in	 the	 lowest	concentration	of	
150	pg	(Figure	23).	Furthermore,	RNA	stability	studies	with	tg(claudinK:EGFP)	zebrafish	revealed	
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The	 fact	 that	 tdTomato	 control	 injections	 revealed	 mellowed	 death	 rates	 compared	 to	 gpr17	



















Since	OE	of	GPR17	 inhibits	oligodendrocyte	development	and	myelination	 in	mice	 (Chen	et	al.,	
2009),	 it	 was	 first	 examined	 whether	 Gpr17	 OE	 in	 zebrafish	 interferes	 with	 oligodendrocyte	
maturation.	3	dpf	old	tg(claudinK:EGFP)	zebrafish,	injected	with	800	pg	gpr17	RNA	were	imaged	
at	 3,	 4	 and	 5	 dpf	 by	 Two-photon	microscopy	 and	 cell	 numbers	 were	 ascertained	 by	 counting	
claudin	K	positive	cells	in	the	dorsal	region	of	the	spinal	cord.	Tg(claudinK:EGFP)	zebrafish	exhibit	
expression	 of	 exaggerated	 green	 fluorescent	 protein	 (EGFP)	 that	 is	 driven	 by	 the	 claudin	 k	
promoter	(Münzel	et	al.,	2012),	hence	EGFP	is	representative	for	the	generation	of	Claudin	k	and	
differentiation	 of	 oligodendrocyte	 lineage	 cells.	 Numbers	 of	 claudin	 k	 positive	 cells	 did	 not	















To	 question	 whether	 unaltered	 numbers	 of	 myelinating	 oligodendrocytes	 in	 overexpressed	
zebrafish	 mirror	 myelin	 formation,	 expression	 of	 myelin	 proteins	 was	 analysed	 by	
Immunohistochemistry	 (IHC)	 and	 Western	 blot	 analysis.	 At	 first,	 expression	 of	 Myelin	 basic	
protein	 (Mbp)	was	determined	 in	 the	 spinal	 cord	of	4	dpf	old	RNA	 injected	zebrafish	 larvae	by	
Whole-mount	 IHC	analysis.	By	using	an	antibody	 to	Mbp,	 generated	data	 revealed	 that	OE	did	
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Injected	 zebrafish	 exhibited	no	difference	 in	Myelin	basic	 protein	 expression	 in	 the	 anterior	 (A)	 and	 the	
middle	(B)	region	of	the	spinal	cord	compared	to	tdTomato	injected	and	uninjected	animals,	evaluated	by	
immunolabelling	 for	 Mbp.	 Data	 are	 shown	 are	 lateral	 views	 (dorsal	 up,	 anterior	 to	 the	 left)	 from	 two	
independent	experiments.	
Furthermore,	 Western	 blot	 analysis,	 evaluating	 the	 expression	 of	 myelin-associated	 protein	
Claudin	K	(Münzel	et	al.,	2012)	(Supplementary	Figure	2),	displayed	no	difference	in	expression	













Quantitative	 evaluation	 of	 4	 dpf	 old	 zebrafish	 larvae,	 injected	 with	 800	 pg	 gpr17	 RNA	 displayed	 no	
difference	in	expression	of	myelin	protein	Claudin	K	compared	to	control	animals	(A).	(B)	shows	illustrative	
Western	 blot	 from	 four	 separate	 experiments.	Data	 are	 shown	 as	mean	 values	 (+	 SEM).	un=	 uninjected	
animals,	tom=	tdTomato	injected	animals.	
4.5.1.4 OE	of	Gpr17	does	not	alter	number	of	olig2	positive	dorsally	migrated	OPCs	
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Figure	28:	Oligodendrocyte	 lineage	 cells	 expressing	 transcription	 factor	olig2	 display	normal	migration	
after	 Gpr17	 OE.	 Numbers	 of	 olig2	 positive	 dorsally	 migrated	 cells	 revealed	 no	 significant	 difference	




To	 evaluate	 the	 effect	 of	 Gpr17	 OE	 on	 mbp	 and	 plp	 expression	 levels,	 WISH	 and	 qPCR	
experiments	were	implemented.	To	this	end,	injected	zebrafish	embryos	were	analysed	at	3	and	
4	dpf,	at	the	time	when	myelination	initiates.	At	both	days,	myelin	gene	expression	levels	were	
not	 significantly	 altered	 between	 gpr17	 and	 control	 group,	 as	 measured	 by	 qPCR	 (Figure	 29).		
Even	 the	 slight	 increase	 in	 plp	 expression	 in	 4	 dpf	 old	 animals	 displayed	 no	 significant	
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4	dpf	 by	qPCR.	 Expression	 levels	 of	mbp	 (A,	B)	 and	plp	 (C,	D)	were	not	 significantly	 altered	between	all	
groups.	Mean	values	(+	SEM)	of	four	independent	were	summarized,	each	performed	in	triplicates	with	25	
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dpf	 old	 zebrafish	 embryos	 revealed	 similar	 expression	of	mbp	 in	 the	CNS	 at	 the	 level	 of	 the	 spinal	 cord	





turn	 into	 pre-OLs	 and	 finally	 into	 mature	 myelinating	 oligodendrocytes,	 while	 OPCs	 lacking	
Nkx2.2	 remain	 as	 non-myelinating	 progenitor	 cells	 (Kucenas,	 Snell	 and	 Appel,	 2010).	 Since	
preceding	results	of	 this	 thesis	demonstrated	that	both,	generation	of	OPCs	and	differentiation	
into	myelinating	oligodendrocytes	are	not	 impaired	by	Gpr17	OE,	 it	was	to	 investigate	whether	
OE	 influences	 the	 initial	 stage	 of	 differentiation	 at	 the	 level	 of	 nkx2.2	 expressing	 pre-OLs.	
Therefore,	WISH	of	2.5	dpf	old	zebrafish	embryos	was	conducted.	Expression	of	nkx2.2	gene	 in	












Figure	 31:	WISH	 of	 2.5	 dpf	 old	 zebrafish	 embryos	 displays	 equal	 nkx2.2	 expression	 in	 the	 CNS.	WISH	
images	 of	 zebrafish	 embryos	 showed	 no	 difference	 in	 nkx2.2	 expression	 between	 gpr17	 and	 control	

























cell	 stage	 and	 effects	 on	 oligodendrocyte	 progression	 were	 evaluated	 by	 distinct	 methods	
throughout	the	first	days	of	development.	
	
Figure	 32:	 Structure	 of	 morpholino	 antisense	 oligonucleotide	 and	 native	 DNA.	 25	 base	 pairs	 long	
morpholino	antisense	oligonucleotides	 containing	an	altered	backbone	bind	 to	 complementary	DNA	and	
inhibit	the	translation	process.	Figure	adapted	from	(Corey	and	Abrams,	2001).	
	 	




Injections	 of	 2.75	 ng	 zfAgpr17	 morpholino	 (MO)	 at	 the	 one-cell	 stage	 of	 zebrafish	 embryos	
caused	weak	phenotypes,	exhibiting	smaller	sizes	and	heart	oedema,	while	control	MO	injected	
compared	to	uninjected	animals	did	not	display	any	abnormalities	(Figure	33).	However,	because	
the survival	 rate	 of	 zfAgpr17	morphants	 compared	 to	 control	 and	 uninjected	 animals	was	 not	





MO	 injected	 and	 uninjected	 zebrafish.	 Shown	 are	 representative	 images	 of	 at	 least	 three	 independent	
experiments.	
4.5.2.2 Western	blot	analysis	confirm	zfAGpr17	knockdown	
To	 verify	 the	 specificity	 of	 zfAgpr17	 MO,	 zfAGpr17	 expression	 in	 3,	 4	 and	 5	 dpf	 old	 zebrafish	
embryos	was	determined	by	Western	blot	analysis	after	injection	of	2.75	ng	MO.	Protein	analysis	
revealed	 a	 decrease	 in	 Gpr17	 expression	 levels	 in	 zfAGpr17	 morphants	 compared	 to	 control	
animals	 (Figure	 34).	 However,	 the	 reduction	 displayed	 only	 significance	 in	 4	 dpf	 old	 embryos	
(P<0.05,	two-way	ANOVA)	(Kleinert,	2018).		
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Figure	 34:	 Western	 blot	 analysis	 reveal	 Gpr17	 knockdown	 after	 injection	 of	 zfAgpr17	 morpholino.	
Zebrafish	 embryos	 injected	 with	 2.75	 ng	 zfAgpr17	 MO	 displayed	 decreased	 Gpr17	 expression	 levels	
compared	 to	 control	 and	 uninjected	 animals,	while	 reduction	was	 only	 significant	 in	 4	 dpf	 old	 embryos	
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knockout	mice	 (Chen	 et	 al.,	 2009),	 expression	 of	 myelin	 proteins	 in	 zfAGpr17	morphants	 was	
analysed	by	Whole-mount	IHC	and	Western	blot	assays.		
Using	an	anti-Mbp	antibody,	Myelin	basic	protein	expression	was	imaged	in	the	spinal	cord	of	4	




Figure	 35:	 Mbp	 expression	 in	 the	 spinal	 cord	 of	 4	 dpf	 old	 zebrafish	 embryos	 is	 impaired	 following	
zfAGpr17	 knockdown.	 Lateral	 views	 (dorsal	 up,	 anterior	 to	 the	 left)	 of	 zebrafish	 embryos	 (C,D)	 injected	
with	zfAgpr17	and	control	MO	were	obtained	at	4	dpf.	Whole-mount	IHC	was	conducted	with	an	antibody	
directed	 against	Mbp	 coupling	 to	 an	 AlexaFluor546-conjugated	 goat	 anti-guinea	 pig	 antibody.	 One-way	
ANOVA	test	comparing	MO	with	control	MO	injected	zebrafish	embryos,	revealed	a	significant	reduction	in	



































































Additionally	 expression	 of	 myelin-associated	 protein	 Claudin	 K	 and	 myelin	 Protein	 zero	 (P0)	
(Schweitzer,	 Becker	 and	 Becker,	 2003)	 in	 4	 dpf	 old	 zebrafish	 was	 examined	 by	 Western	 blot	
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4.5.2.3 WISH	 demonstrates	 reduced	 expression	 of	 myelin	 basic	 protein	 in	 zfAGpr17	
morphants		
In	 order	 to	 strengthen	 the	 IHC	 assay	 revealing	 narrowed	Mbp	expression	 in	 the	 spinal	 cord	 of	
zfAgpr17	 morpholino	 injected	 zebrafish	 (Figure	 35),	 expression	 of	 mbp	 at	 the	 level	 of	
transcription	was	ascertained	by	WISH.		
Thereby,	mbp	 signal	 in	 MO	 injected	 zebrafish	 was	 compared	 to	 control	 MO	 injected	 and	WT	
animals	at	3	and	4	dpf.	While	expression	of	myelin	basic	protein	was	remarkably	reduced	in	the	
CNS	and	in	the	PNS	of	3	dpf	old	morphants	(Figure	37,	A),	the	difference	was	less	noticeable	at	4	
dpf	 (Figure	 37,	 B).	Moreover,	 similarly	 assayed	 tg(olig2:EGFP)	 zebrafish,	 sorted	 by	 fluorescent	











One	 explanation	 for	 the	 narrowed	myelination	 in	 zfAGpr17	morphants	 could	 be	 fewer	mature	
oligodendrocytes.		
To	 test	 this,	 Two-photon	 microscopy	 images	 of	 representative	 spinal	 cord	 regions	 of	
tg(claudink:EGFP)	 zebrafish	 were	 acquired	 to	 quantify	 cell	 numbers	 in	 zfAgpr17	 MO	 injected	
embryos.	 At	 3	 dpf,	 zfAGpr17	 morphants	 revealed	 a	 significantly	 reduced	 number	 of	 dorsally	
migrated	 claudin	 k	 positive	 oligodendrocytes	 (P<0.0025,	 one-way	 ANOVA)	 compared	 with	 the	
controls	(Figure	38),	indicating	diminished	oligodendrocyte	maturation.		
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Tg(claudink:EGFP)	 zebrafish,	 injected	 with	 2.75	 ng	 zfAgpr17	 MO	 RNA	 were	 imaged	 by	 Two-photon	
microscopy	at	3	dpf.	Numbers	of	dorsally	migrated	claudin	k	positive	cells	 significantly	differed	between	





Since	oligodendrocytes	 differentiate	 from	Olig2	positive	OPCs,	 it	was	 to	delineate	whether	 the	




ANOVA)	 in	 the	 percentage	 of	 olig2	 positive	 cell	 numbers	 in	 mutant	 embryos	 compared	 with	
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2.75	 ng	 zfAgpr17	MO	 in	 tg(olig2:EGFP)	 zebrafish	 caused	 a	 significant	 reduction	 in	olig2	 positive	 dorsally	
migrated	 cells	 in	 morphants	 compared	 to	 control	 injected	 and	 WT	 animals	 (A).	 Results	 achieved	 with	
EnSight®	plate	reader	confirmed	data	obtained	by	Two-photon	microscopy	(B).	Figure	(C)	presents	lateral	
views	(dorsal	up,	anterior	to	the	left)	of	representative	spinal	cord	regions.	Shown	are	mean	values	(±	SEM)	
from	 three	 independent	 experiments.	 ****;	 P<0.0001	 according	 to	 one-way	 ANOVA	 using	 Bonferroni’s	
multiple	comparison	test.	Results	obtained	with	EnSight®	were	generated	by	Enrico	Mingardo	in	the	lab	of	
Prof.	Dr.	Evi	Kostenis,	University	of	Bonn.	
Collectively,	 the	 imaging	 data	 demonstrate,	 that	 zfAGpr17	 knockdown	 reduces	 numbers	 of	
dorsally	located	oligodendrocyte	lineage	cells	in	two	stages	of	development,	at	the	level	of	OPC	
proliferation/migration	 and	 at	 the	 level	 of	 oligodendrocyte	 differentiation.	Hence,	 the	 reduced	
cell	 numbers	 could	 result	 either	 from	 decreased	 OPC	 proliferation	 and	 differentiation,	 and/or	
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To	 determine	 whether	 the	 reduced	 numbers	 of	 oligodendrocyte	 lineage	 cells	 in	 zfAGpr17	
morphants	 resulted	 from	 increased	 cell	 death,	 whole-mount	 zebrafish	 embryos,	 injected	 with	
zfAgpr17	and	control	MO	were	labelled	for	the	active	form	of	Caspase-3	(Cleaved	Caspase-3)	at	3	
dpf.	Numbers	of	 cells	 that	 stained	positive	 for	Caspase-3	did	not	markedly	differ	 between	MO	





MO	by	 IHC	assay.	Cells	 stained	positive	 for	Cleaved	Capsase-3	 (white	arrow)	were	not	markedly	present	





As	 expression	 of	 the	 transcription	 factor	 Nkx2.2	 initiates	 the	 terminal	 differentiation	 pathway,	
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Figure	41:	Nkx2.2	 expression	 in	 the	 spinal	 cord	of	 zfAGpr17	morphants	was	markedly	 increased	at	2.5	
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4.5.2.8 zfAgpr17	 RNA	 rescues	 morpholino-induced	 reduction	 of	 dorsally	 migrated	
oligodendrocyte	lineage	cells		
Since	 preceding	 studies	 revealed	 that	 OE	 of	 Gpr17	 by	 RNA	 injections	 did	 not	 affect	
oligodendrocyte	development,	one	could	argue	that	protein	is	not	translated.	Hence,	the	ability	
of	zfAgpr17	RNA	to	rescue	MO-induced	reduction	of	dorsally	migrated	cells	was	determined	by	
co-injection	 of	 zfAgpr17	 MO	 and	 RNA.	 As	 expected,	 injections	 of	 zfAgpr17	 MO	 caused	 a	






Figure	 42:	 Reduction	 in	 numbers	 of	 olig2	 positive	 cells	 in	 zfAGpr17	 morphants	 can	 be	 rescued	 by	
zfAgpr17	 RNA.	 Gpr17	 rescue	was	 evaluated	 by	 imaging	 representative	 spinal	 cord	 regions	 of	 3	 dpf	 old	
tg(olig2:EGFP)	zebrafish	embryos,	injected	with	zfAgpr17	MO	alone	as	well	as	together	with	zfAgpr17	RNA.	
While	MO	injected	animals	displayed	a	significant	difference	in	number	of	dorsally	migrated	olig2	positive	
cells	 compared	 to	 control	 injected	 animals,	 the	 reduction	 was	 completely	 rescued	 after	 co-injection	 of	
zfAgpr17	MO	with	RNA	 (A).	 (B)	 shows	 representative	 lateral	 views	 (dorsal	up,	 anterior	 to	 the	 left).	Data	
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constitutes	the	basis	 for	several	neurophysiological	processes	 in	 the	vertebrate	nervous	system	
(Pfeiffer,	 Warrington	 and	 Bansal,	 1993).	 However,	 to	 date,	 the	 underlying	 mechanism	 of	
myelination	is	not	completely	clarified;	consequently,	ongoing	research	in	this	field	is	crucial.	An	
improved	understanding	of	myelination	would	further	support	the	investigation	of	diseases	such	
as	multiple	 sclerosis	 (MS)	 (Compston	 and	 Coles,	 2008),	 Alzheimer’s	 disease	 (George	 Bartzokis,	
2011),	cerebral	palsy	(Azzarelli	et	al.,	1996)	or	schizophrenia	(Azzarelli	et	al.,	1996),	all	displaying	
demyelination	as	pathological	feature.	
Recently,	 G-protein	 coupled	 receptors	 have	 been	 identified	 as	 key	 regulators	 during	
oligodendrocyte	 development	 and	 myelination	 (Mogha,	 Rozario	 and	 Monk,	 2016),	 and	 may	
therefore	 promise	 new	 targets	 in	 the	 treatment	 of	 demyelinating	 diseases.	 One	 of	 them,	 the	
orphan	 rhodopsin	 family	 G-protein	 coupled	 receptor	 17,	 which	 is	 enriched	 in	 oligodendrocyte	
lineage	 cells,	 has	 been	 implicated	 in	 the	 maturation	 of	 oligodendrocytes	 (Chen	 et	 al.,	 2009;	
Fumagalli	et	al.,	 2011).	 In	addition	 to	 its	 role	during	oligodendrocyte	development,	GPR17	was	
found	 to	 be	 upregulated	 in	 human	 white	 matter	 plaques	 of	 MS	 patients	 (Chen	 et	 al.,	 2009).	
However	 its	 function	 in	 the	 disease	 remains	 speculative	 at	 the	 time.	 Despite	 the	 intensive	
knowledge	 about	 this	 GPCR,	 published	 literature	 reveals	 inconsistences	 concerning	 expression	
pattern,	role	and	activation	by	distinct	ligands;	thus,	there	is	an	urgent	need	of	further	research	
clarifying	outstanding	issues	(Marucci	et	al.,	2016).	
Herein,	 the	 zebrafish	 (Danio	 rerio),	 a	 freshwater	 teleost	 (Kari,	Rodeck	and	Dicker,	2007),	might	
represent	 a	 potential	 model	 organism	 to	 gain	 new	 insights	 in	 the	 role	 of	 Gpr17	 in	
oligodendrocyte	myelination,	not	only	during	development	but	also	in	disease.	This	chapter	will	
discuss	receptor	functionality	of	zebrafish	Gpr17	examined	in	in	vitro	and	in	vivo	assays	as	well	as	
the	 potential	 of	 artificial	 chimeric	 Gpr17	 receptors	 as	 promising	 screening	 tools.	 Furthermore,	
specific	 in	 vivo	 results	 concerning	 receptor	 expression	 and	 function	 will	 be	 discussed	 and	










deorphaning	 report,	 follow-up	 studies	 by	 the	 same	 group	 examined	 function	 of	 this	 receptor	
during	 oligodendrocyte	 development	 by	 using	 the	 two	 family	 ligands,	with	 the	 conclusion	 that	
Gpr17	 activation	 promotes	 oligodendrocyte	maturation	 (Lecca	et	 al.,	 2008;	 Ceruti	et	 al.,	 2009;	
Fumagalli	et	al.,	2011).	However,	Gpr17	activation	 through	 the	proposed	agonists	could	not	be	
verified	by	several	 independent	 laboratories	(Heise	et	al.,	2000;	Maekawa	et	al.,	2009;	Benned-
Jensen	 and	 Rosenkilde,	 2010;	 Simon	 et	 al.,	 2017).	 Additionally,	 Hennen	 and	 collaborators	
identified	 a	 small-molecule	 agonist,	 MDL29,951,	 which	 activated	 Gpr17	 mainly,	 but	 not	
exclusively,	 via	 the	 Gαi/o	 pathway	 in	 a	 concentration-dependent	 manner.	 Noteworthy,	
experimental	 results	 from	 this	 group	emphasised	 an	 inhibitory	 role	of	Gpr17	on	maturation	of	
oligodendrocytes	 (Hennen	 et	 al.,	 2013a;	 Simon	 et	 al.,	 2016),	 in	 agreement	 with	 reports	 from	
several	independent	laboratories	(Chen	et	al.,	2009;	Daniele	et	al.,	2014).	
In	 an	 attempt	 to	 clarify	 these	 conflicting	 data,	 ongoing	 research	 should	 focus	 on	 finding	 new	
model	 systems	 in	which	 the	 activation	 and	 role	 of	Gpr17	 can	 be	 analysed.	While	 prior	 studies	
utilized	 rodent	 models	 to	 study	 Gpr17	 in	 myelination	 (Lecca	 et	 al.,	 2008;	 Chen	 et	 al.,	 2009;	
Fumagalli	et	al.,	2011;	Hennen	et	al.,	2013a;	Simon	et	al.,	2016),	future	efforts	might	consider	the	
smaller	vertebrate	model	zebrafish,	which	displays	a	powerful	alternative	to	study	myelination	in	
vivo	 (Driever	 et	 al.,	 1994;	 Buckley,	 Goldsmith	 and	 Franklin,	 2008;	 Ackerman	 and	Monk,	 2015;	
Preston	 and	 Macklin,	 2015).	 Hence,	 primary	 experiments	 of	 this	 work	 aimed	 to	 answer	 two	
questions:	firstly,	whether	zebrafish	Gpr17	can	be	activated	by	postulated	uracil	nucleotides	and	
cysteinyl	 leukotrienes;	 and	 secondly,	 whether	 MDL29,951	 could	 induce	 robust	 responses	
comparable	to	those	on	human,	mouse	and	rat	Gpr17	(Hennen	et	al.,	2013).		
The	data	obtained	in	label-free	Dynamic	mass	redistribution	assays	revealed	missing	responses	of	
zebrafish	Gpr17	 transfected	mammalian	HEK293	 cells	 towards	 both	 the	 proposed	 endogenous	
agonists	and	MDL29,951.	The	 lack	of	activity	of	uracil	nucleotides	and	cysteinyl	 leukotrienes	on	
zebrafish	Gpr17	was	rather	expected	and	entirely	consistent	with	previous	observations	showing	
unresponsiveness	 of	 human,	 mouse	 and	 rat	 Gpr17	 in	 various	 recombinant,	 immortalized	 and	
primary	cells	(Simon	et	al.,	2017).	Thus,	the	notion	of	Simon	and	collaborators	considering	Gpr17	





a	 similar	 manner.	 The	missing	 response	may	 be	 grounded	 on	 three	 reasons:	 Firstly,	 zebrafish	
Gpr17	 is	 insufficiently	 expressed	 in	 the	 cell	 membrane	 of	 the	 mammalian	 HEK293	 cell	 line.	
Secondly,	 the	 intracellular	 interaction	 between	 the	 zebrafish	 receptor	 and	 the	 mammalian	 G-	
proteins	is	circumvented.	Thirdly,	the	small	molecule	agonist	does	not	bind	appropriately	to	the	
zebrafish	receptor.		
Beginning	 with	 the	 membrane	 availability	 of	 the	 receptor,	 ELISA	 and	 ICC	 assays	 verified	 its	
expression	on	 the	cell	 surface,	 thus	a	 lack	of	 response	based	on	missing	membrane	expression	
can	 be	 actually	 excluded.	 Nevertheless,	 it	 might	 be	 possible	 that	 zebrafish	 receptors	 need	
increased	 expression	 levels	 in	mammalian	 cell	 lines	 for	 an	 appropriate	 detectable	 signaling.	 A	
future	 generation	 of	 a	 stable	 cell	 line	 expressing	 the	 zebrafish	 Gpr17	 at	 a	 higher	 level	 than	
transient	 transfected	 cells	 might	 offer	 better	 signalling	 conditions	 in	 the	 extrinsic	 mammalian	
background.		
Intricacies	 in	 the	 analysis	 of	 zebrafish	 receptors	 in	 mammalian	 cell	 lines	 have	 already	 been	
described	by	existing	literature.	Studies	of	Ringvall	and	collaborators	demonstrated	lower	binding	
affinities	and	less	potency	of	zebrafish	neuropeptide	Y	(NPY)	receptors	in	CHO	cells	compared	to	
mammalian	 NPY	 receptors	 (Ringvall,	 Berglund	 and	 Larhammar,	 1997).	 Thereby,	 inappropriate	
interaction	 of	 mammalian	 G-proteins	 with	 zebrafish	 receptors	 was	 assumed	 to	 be	 the	 cause.	
Within	 this	work,	 this	assumption	was	supposed	to	be	resolved	by	use	of	a	zebrafish	 fibroblast	




with	 zfBGpr17.	 Moreover,	 according	 to	 mutagenesis	 studies	 (unpublished	 data),	 the	 residue	
motif	 involved	 in	 receptor	 activation	 by	 MDL29,951	 is	 identical	 from	 zebrafish	 to	 mammals.	
Therefore,	considering	the	level	of	conservation,	there	are	no	actual	reasons	for	a	lack	of	agonist	




chimeras	 containing	 the	human	binding	domain	 region	and	either	 zfA	or	 zfBGpr17	 intracellular	
loops	 showed	 functionality	 after	 stimulation	 with	 MDL29,951,	 although	 the	 responses	 were	
diminished	 compared	 to	human	Gpr17.	 Conversely,	 chimeric	 receptors	 exhibiting	 the	 zebrafish	
Discussion	
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binding	 domain	 remained	 unresponsive,	 despite	 containing	 the	 human	 intracellular	 loops	
responsible	for	the	interaction	with	G-proteins	in	HEK293	cells.	Altogether,	these	results	suggest	





37°C.	 The	 temperature	 may	 influence	 the	 folding	 of	 the	 receptor	 and	 the	 following	 signalling	
behaviour.	 Thus,	 it	 could	 have	 occurred	 that	 although	membrane	 expression	was	 present,	 the	




The	 highly	 important	 research	 area	 of	 developmental	 and	 disease	 biology	 has	 been	
complemented	during	the	last	two	decades	by	the	small	fresh-water	vertebrate	zebrafish	since	it	
provides	 an	 ideal	 in	 vivo	model	organism	 for	 gene	and	 target	 validation,	 as	well	 as	 for	disease	
investigations.	 The	 high	 genome	 conservation	 between	 zebrafish	 and	 humans	 makes	 them	 a	
popular	 and	 currently	 used	 model	 organism	 in	 many	 important	 medical	 areas	 (Langheinrich,	
2003;	Taylor	et	al.,	2010;	Howe	et	al.,	2013).	Especially	in	the	field	of	myelination,	several	genes	
and	 cell	 lineage	 properties	 are	 highly	 conserved	 between	 zebrafish	 and	 mammals,	 wherefore	




suited	for	this	purpose	 is	the	zebrafish	embryo	since	 it	 is	permeable	to	drugs	and	can	be	easily	
genetically	 modified.	 For	 instance,	 Buckley	 et	 al.	 used	 a	 transgenic	 reporter	 line	 for	 high-
throughput	screening	of	drugs	with	pro-myelinating	features.	Compounds	that	altered	numbers	
of	oligodendrocyte	lineage	cells	were	further	examined	by	qPCR	and	finally	evaluated	in	tertiary	
screens	 for	 suitability	 for	 research	 progression	 (Buckley	 et	 al.,	 2010).	 Likewise,	 Fang	 et	 al.	
demonstrated	 that	 treatment	 of	 zebrafish	 embryos	 with	 metronidazole	 caused	 demyelination	




Accordingly,	 an	 effect	 of	 MDL29,951	 acting	 on	 zebrafish	 Gpr17	 and	 thereby	 influencing	 the	
myelination	process	could	be	examined	 in	an	analogous	way.	On	 this	occasion,	 functionality	of	
zebrafish	Gpr17	would	be	analysed	 in	 its	native	signalling	environment.	Obviously,	 this	method	
cannot	 exclude	 target	 unspecific	 effects	 and	 merely	 yields	 an	 indirect	 way	 to	 analyse	
responsiveness	 of	MDL29,951	 at	 zebrafish	 Gpr17.	 However,	 it	 substantiates	 evidence	whether	




K	 positive	 oligodendrocytes	 of	 treated	 and	 control	 animals	 were	 evaluated	 at	 5	 dpf.	 While	
Buckley	et	al.	screened	for	immature	oligodendrocyte	precursor	cells	at	earlier	time	points,	hence	
achieving	 further	 premonitions	 about	 cell	 proliferation	 and	migration,	 experiments	 within	 this	
work	 rather	 focused	on	myelin	producing	cells,	 aiming	 to	mirror	myelination.	The	 results	 show	
that	MDL29,951	treatment	of	zebrafish	embryos	for	 five	days	did	not	change	claudin	K	positive	
oligodendrocyte	 numbers,	 thus	 indicating	 no	 altered	 oligodendrocyte	 development	 nor	
myelination.	This	was	further	confirmed	by	Western	blot	analysis	of	5	dpf	old	embryos	revealing	
stable	 expression	 of	 myelin	 protein	 36k	 after	 MDL29,951	 treatment	 compared	 to	 untreated	
controls.	 Noteworthy,	 36k,	 a	 newly	 discovered	 myelin	 protein	 that	 was	 found	 to	 be	 highly	
expressed	in	oligodendrocytes	of	zebrafish	(Morris	et	al.,	2004),	may	not	represent	myelination	in	
the	approved	manner	as	prominent	myelin	proteins	such	as	Mbp	or	Plp	(Schweitzer	et	al.,	2006;	
Nawaz	 et	 al.,	 2013).	 However,	 antibodies	 detecting	 zebrafish	 Mbp	 and	 Plp	 did	 not	 work	 in	
Western	 blot	 analysis.	 Nevertheless,	 qPCR	 analysis	 reflected	 unaltered	 expression	 of	 myelin	
genes	 mbp	 and	 plp	 after	 MDL29,951	 treatment,	 further	 supporting	 the	 36k	 analysis.	 It	 is	
important	to	note	that	a	disadvantage	of	Western	blot	and	qPCR	studies	constitutes	the	sample	






in	preceding	 in	 vitro	 experiments	 and	plead	once	more	 for	 impaired	 ligand	binding.	 Therefore,	







from	 lion,	 goat	 and	 serpent,	 in	 the	 scientific	 literature	 the	 designation	 stands	 for	 molecules	
composed	 of	 domains	 from	 various	 receptors.	 Especially,	 the	 7-transmembrane	 G-protein	
coupled	 receptors	 comprising	 three	 basic	 domains	 (extracellular,	 intracellular	 and	
transmembrane	 region)	 can	be	perfectly	 converted	 into	 chimeras.	During	 the	 last	 two	decades	
several	 independent	 research	 groups	 established	 more	 than	 100	 chimeric	 receptors	 to	 study	
inter	alia	ligand	binding	and	downstream	signalling	(Yin	et	al.,	2004).	
While	existing	literature	occasionally	reports	about	chimeric	receptors	consisting	of	homologous	
receptors,	 first	 time	within	 this	work,	 orthologous	Gpr17	 receptors	 from	 zebrafish	 and	 human	
were	merged	 into	 chimeras	with	 the	 view	 to	 unravel	 the	 unresponsiveness	 of	 zebrafish	Gpr17	
towards	 a	 small	 molecule	 agonist.	 As	 described	 in	 preceding	 chapters,	 DMR	 assays	 proved	
functionality	 of	 chimeras	 containing	 the	 human	 binding	 site	 upon	 activation	 with	MDL29,951,	
while	 receptors	exhibiting	 the	zebrafish	binding	domain	remained	unresponsive.	The	 functional	
chimeric	 receptors	 provoked	 varied	 DMR	 traces	 and	 2-fold	 lower	 responses	 than	 those	 of	 the	
human	 Gpr17.	 One	 of	 the	 reasons	 for	 the	 constrained	 responses	 was	 the	 2-fold	 decreased	
membrane	 expression	 compared	 to	 the	 human	 receptor.	 The	 phenomenon	 of	 declined	
expression	of	 chimeric	 receptors	 is	 also	 found	 in	different	 studies	 (e.g.,	Gearing	et	al.	 studying	
ligand	 binding	 of	 chimeric	 leukotriene	 receptors	 (Gearing	 et	 al.,	 2003)).	 A	 second	 reason	 was	
elucidated	in	further	experiments	that	analyzed	chimeric	Gpr17	receptors	in	the	presence	of	the	
G-protein	 inhibitors	 pertussis	 toxin	 (PTX)	 and	 UBO-QIC.	 The	 obtained	 data	 revealed	 exclusive	




compounds	 with	 activating	 or	 inhibiting	 properties	 on	 human	 Gpr17.	 Stably	 expressed	 in	
different	zebrafish	reporter	 lines,	endogenous	zebrafish	signalling	pathways	would	be	triggered	
while	 ligand	 binding	 and	 receptor	 activation	 would	 proceed	 as	 in	 humans.	 On	 this	 occasion,	
compounds	that	alter	myelination	in	zebrafish	would	allow	drawing	conclusion	concerning	effects	
in	humans.	Nevertheless,	 the	 reduced	membrane	expression	and	 impaired	signalling	behaviour	
of	 chimeric	 receptors	 observed	 in	 the	 mammalian	 cell	 line	 should	 not	 be	 disregarded	 when	




sense,	 to	 prevent	 biased	 results,	 the	 expression	 of	 chimeras	 in	 zebrafish	 Gpr17	 null	 mutants	
should	 be	 also	 considered.	 Although	MDL29,951	 failed	 in	 activating	 zebrafish	Gpr17,	 this	 does	
not	mean	that	other	compounds	act	in	the	same	way.		
To	 conclude,	 Gpr17	 chimeras	 would	 indeed	 facilitate	 the	 in	 vivo	 screening	 of	 human	 Gpr17	
targeting	 compounds,	 although	 their	 usability	 in	 vivo	 has	 to	 be	 shown	 in	 future	 experiments.	
Before	 this,	 however,	 additional	 investigations	 have	 to	 prove	 a	 crucial	 role	 of	 Gpr17	 in	
myelination	of	the	aquatic	vertebrate	zebrafish.	
5.1.4 Gpr17	is	expressed	in	developmental	stages	of	zebrafish	CNS		
In	2006,	Kirby	et	al.	 illustrated	oligodendrocyte	development	and	myelination	 in	zebrafish	by	 in	
vivo	 time-lapse	 imaging	 of	 transgenic	 reporter	 lines.	 Confocal	 images	 of	 zebrafish	 embryos	
revealed	that	at	2	dpf,	OPCs	derived	from	NP	cells	start	migrating	dorsally	from	the	pMN	region	
in	 the	neural	 tube.	Once	 they	 stop	proliferating	and	migrating,	OPCs	differentiate	 into	pre-OLs	
that	finally	transition	into	myelinating	oligodendrocytes,	so	that	at	5	dpf	first	myelin	sheaths	can	
be	 observed.	 Consistent	 with	 this	 reported	 zebrafish	 oligodendrocyte	 development,	 WISH	
experiments	of	this	work	displayed	an	expression	pattern	of	gpr17	RNA	within	the	first	five	days	
of	zebrafish	development.	Deletion	of	OPCs	with	TSA	(Takada	et	al.,	2010)	 induced	a	significant	
demise	of	gpr17	expression	 in	the	dorsal	spinal	cord	region,	 thus	suggesting	Gpr17	presence	 in	
dorsally	migrated	 oligodendrocyte	 lineage	 cells	 in	 zebrafish.	 Remarkably,	 diffuse	 expression	 of	
gpr17	 is	detected	already	at	1	dpf	within	 the	dorsal	 and	 the	ventral	 spinal	 cord,	 suggesting	an	
existence	 of	 gpr17	 before	 initiation	 of	 oligodendrocyte	 development.	 This	 presumption	 was	
previously	 described	 by	 Maisel	 et	 al.	 proposing	 gpr17	 gene	 as	 marker	 of	 adult	 NG2	 positive	
progenitor	cells	of	human	hippocampus	(Maisel,	Herr,	et	al.,	2007).	Whether	Gpr17	is	expressed	





simultaneous	 signal	 amplification	 of	 gpr17	 RNA	 with	 olig2	 or	 claudin	 K	 by	 RNAscope	
technology®,	or	by	IHC	assays	detecting	the	corresponding	proteins.	
In	addition	to	WISH	analysis	that	visualized	expression	of	gpr17	RNA,	implemented	Western	blot	







To	 sum	 up,	 experiments	 of	 this	 work	 demonstrate	 Gpr17	 expression	 during	 zebrafish	 CNS	








target	 identification	 and	 validation	 studies.	 Thus,	 zebrafish	 provide	 prominent	 platforms	 for	
genetic	 screens,	 either	 for	 forward	 screenings	 to	 identify	 mutated	 genes	 after	 inducing	
phenotypes	 by	 chemical	 mutagenesis	 or	 for	 investigations	 of	 specific	 phenotypes	 following	
mutations	of	disease-related	 targets.	The	 latter,	also	known	as	 reverse	 screening,	usually	 takes	
advantage	of	overexpression	 (OE)	and	knockout	 (KO)	methodologies	 implemented	 inter	alia	by	
use	 of	 the	 CRISPR/cas9	 system	 (Yoganantharjah	 and	 Gibert,	 2017).	While	 transient	 OE	 can	 be	
quickly	 achieved	 by	 injection	 of	 mRNA	 or	 plasmid	 DNA	 into	 the	 one-cell	 stage	 of	 zebrafish	
embryos,	the	generation	of	KO	animals	takes	far	longer.	A	timesaving	alternative	represents	the	
morpholino	 (MO)-induced	 gene	 knockdown.	 By	 complementary	 binding	 of	 backbone-altered	
oligomers	 to	 specific	 nucleic	 acid	 sequences,	 the	 translation	machinery	 is	 impaired	 (Corey	 and	
Abrams,	 2001).	 Noteworthy,	 during	 the	 last	 15	 years	 an	 growing	 number	 of	 scientists	 claimed	
about	MO-induced	off-target	effects	causing	misleading	results	and	thus	degrading	their	scientific	
relevance	 (Blum	et	al.,	 2015).	However,	 Stainier	 and	 co-workers	 recently	published	a	 guideline	
recommending	 utility	 of	 MO	 oligomers	 while	 taking	 account	 of	 some	 rules,	 for	 instance	 by	
verifying	MO-induced	effects	 in	rescue	experiments	 (Stainier	et	al.,	2017).	Hence,	 for	validating	
the	 role	of	Gpr17	during	oligodendrocyte	development	and	myelination,	Gpr17	expression	was	
manipulated	 by	 injections	 of	 3HA-tagged	 zfgpr17	mRNA	 or	MO	 oligonucleotides	 into	 one-cell	
stage	zebrafish	embryos.		
Transient	OE	of	Gpr17	within	the	first	days	of	zebrafish	life	had	no	influence	on	oligodendrocyte	
development	 or	 myelination.	 Imaging	 results	 of	 transgenic	 reporter	 lines	 revealed	 unaltered	
numbers	of	oligodendrocyte	lineage	cell	 in	both,	pre-mature	and	mature	developmental	stages.	
In	 addition,	 comparable	 expression	 pattern	 of	 the	 transcription	 factor	nkx2.2	 labelling	 pre-OLs	
indicated	 neither	 premature	 nor	 delayed	 initiation	 of	 oligodendrocyte	 development.	 Finally,	
unchanged	 expression	 of	 myelin	 genes	 such	 as	mbp	 and	 plp,	 evaluated	 by	 qPCR	 and	 WISH,	
coincided	with	Mbp	 expression	 obtained	 in	 IHC	 assays	 as	well	 as	myelin	 protein	 expression	 in	
Western	blot	analysis.	These	results	may	question	the	successful	OE	of	Gpr17;	however,	control	







protein	 could	 be	 expressed	 in	 each	 cell	 type,	 while	 the	 abundance	 in	 cells	 endogenously	
expressing	the	protein	may	be	insufficient	for	inducing	clear	phenotypes.	This	limitation	could	be	
prevented	by	injecting	the	constructs	together	with	their	promoter,	although	that	is	unknown	for	
Gpr17.	 Alternatively,	 it	 might	 be	 used	 the	 Olig2	 promoter	 to	 drive	 expression	 in	 OPCs	 that	
presumably	express	Gpr17	and	mainly	contribute	to	oligodendrocyte	development.	Whether	this	
would	cause	distinct	phenotypes	might	be	investigated	in	future	studies.	Additionally,	coupling	of	
Gpr17	 with	 EGFP	 and	 subsequent	 injection	 could	 be	 a	 complementary	 alternative	 to	 visualize	
expression	of	Gpr17,	although	 it	 should	be	considered	 the	possibility	 that	 the	 large	 fluorescent	
protein	may	reduce	functionality	in	vivo.		
Intriguingly,	 OE	 of	 Gpr17	 in	mice	 that	 resulted	 in	 hypomyelination	was	 provoked	 in	 late-stage	
oligodendrocytes	 already	expressing	CNPase,	 thus	 at	 a	 time	point	when	Gpr17	 is	 almost	down	
regulated	 (Chen	 et	 al.,	 2009).	 On	 the	 contrary,	 in	 zebrafish	 embryos,	where	gpr17	mRNA	was	
injected	 in	 one-cell	 stage	 embryos,	 OE	 probably	 appears	 even	 before	 Gpr17	 is	 endogenously	
abundant.	Hence,	additional	amounts	of	Gpr17	 in	 that	stage	of	development	might	not	 further	
contribute	to	the	following	effect	of	endogenous	Gpr17,	wherefore	obtained	results	showed	no	
effect	 on	oligodendrocyte	development	 and	myelination.	 In	 comparison,	OE	of	Gpr56,	 another	
GPCR	 that	 is	 essential	 for	 oligodendrocyte	 proliferation	 and	 already	 present	 before	 OPC	
specification,	evoked	preceded	mbp	expression	in	2.5	dpf	old	zebrafish	embryos	(Ackerman	et	al.,	
2015).	 Contrarily	 to	 Gpr17,	 in	 this	 study	 OE	 was	 implemented	 in	 the	 stage	 of	 endogenous	
receptor	expression.		








achieved.	 Subsequently,	 reduced	numbers	of	OPCs	 resulted	 in	 fewer	mature	oligodendrocytes,	
which	failed	to	sufficiently	myelinate	axons.	Impaired	myelination	was	demonstrated	by	reduced	
Mbp	expression	within	the	spinal	cord	and	further	by	Western	blot	analysis	revealing	mellowed	





lineage	 cells.	 This	 observation	 could	 be	 further	 confirmed	 by	 future	 experiments	 quantifying	




being	 restrained	 in	 the	 pMN	 region,	 pre-OLs	 fail	 to	migrate	 into	 the	 dorsal	 spinal	 cord,	which	
finally	leads	to	insufficient	myelination	in	this	region.	
This	hypothesis	approximately	correlates	with	findings	of	Chen	et	al.	demonstrating	a	preceded	
onset	 of	myelination	 in	 Gpr17	 null	 mutant	mice.	 Noteworthy,	 Chen	 and	 collaborators	 did	 not	
examine	numbers	or	migration	of	oligodendrocyte	lineage	cells.	Hence,	it	could	be	possible	that	
pre-mature	 myelin-forming	 oligodendrocytes	 of	 mice	 are	 still	 able	 to	 migrate	 and	 myelinate	
axons,	while	migration	in	zebrafish	might	be	additionally	inhibited	after	Gpr17	knockdown.	If	this	
proves	 true,	migration	 ability	 of	 oligodendrocyte	 lineage	 cells	 could	 be	 examined	 by	 time-laps	
imaging	 of	 distinct	 zebrafish	 reporter	 lines	 such	 as	 tg(olig2:EGFP)	 (Shin	 et	 al.,	 2003)	 or	
tg(nkx2.2a:GFP)	(Pauls	et	al.,	2007).	A	positive	influence	of	Gpr17	on	OPC	migration	was	already	
published	 by	 Coppi	 and	 collaborators	 (2013),	 however	 results	 were	 obtained	 by	 use	 of	 the	
dubious	UDP	ligands.		
Previous	 knockdown	 studies	 using	 specific	 small	 interfering	 RNAs	 (siRNAs)	 in	 primary	 OPCs	
observed	similar	effects	as	this	work,	particularly	reduced	numbers	of	Gpr17	positive	cells	as	well	
as	 mature	 myelin-forming	 oligodendrocytes	 (Fumagalli	 et	 al.,	 2011),	 though	 effects	 on	
myelination	 were	 not	 described.	 Nevertheless,	 one	 should	 be	 cautious	 when	 comparing	
knockdown	 with	 knockout	 results.	 The	 observation	 that	 knockdown	 strategies	 could	 cause	
distinct	 phenotypes	 than	 knockout	 approaches	was	 recently	 described	 in	 literature	 (El-Brolosy	
and	 Stainier,	 2017).	 For	 instance,	 Kok	 et	 al.	 demonstrated	 that	 different	 generated	 zebrafish	
knockout	mutants	could	not	recapitulate	those	phenotypes	obtained	in	previous	MO	knockdown	
studies.	Additionally,	another	working	group	examining	an	endothelial	extracellular	matrix	gene	
(egfl7)	 in	 zebrafish	 uncovered	 severe	 vascular	 defects	 in	MO	 injected	 animals,	 while	 knockout	
mutants	revealed	normal	phenotypes	(Rossi	et	al.,	2015).	










G-protein	 coupled	 receptor	 17	 in	 vivo.	 Receptor	 expression	 in	 the	 CNS	 during	 the	 first	 days	





Gpr17	 additionally	 impacts	 on	 OPCs	 migration	 and	 the	 evidence	 of	 OPC	 pre-maturation	 after	




Since	 the	overall	project	aims	 to	use	zebrafish	as	 screening	platform	 for	 substances	 interacting	
with	Gpr17	to	support	remyelination	in	demyelinating	diseases,	it	should	be	considered	that	this	




While	KO	of	Gpr37	 induced	hypermyelination	during	development	 (Yang	et	al.,	2016),	a	 recent	
study	demonstrated	that	absence	of	Gpr37	in	the	cuprizone	disease	model	resulted	in	increased	






either	 inhibition	 or	 activation	 of	 Gpr17	 positively	 contribute	 to	 the	 disease	 progression.	
Consequently,	further	investigations	clarifying	Gpr17	function	under	pathological	conditions	have	
to	be	driven,	for	instance,	by	use	of	an	adult	MOG-induced	EAE	zebrafish	model	(Kulkarni	et	al.,	
2017)	 or,	 otherwise,	 by	 induction	of	 spinal	 lesions	 in	 adult	 but	 also	 in	 juvenile	 zebrafish	might	
represent	 an	 alternative	 method.	 Nevertheless,	 high-throughput	 screening	 of	 compounds	
affecting	 myelination	 could	 be	 initially	 conducted	 in	 developing	 Gpr17	 zebrafish	 null	 mutants	
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conduction	 (Pfeiffer,	 Warrington	 and	 Bansal,	 1993).	 Although	 intense	 studies	 aimed	 to	 attain	




2016).	 Nevertheless,	 further	 investigations	 are	 required	 to	 finally	 conclude	 about	 function	 of	
GPCRs	in	CNS	development	but	also	in	demyelinating	pathologies	such	as	MS.	
Within	 this	 work,	 the	 zebrafish,	 a	 powerful	 model	 system	 for	 studying	 myelination	 in	 vivo	
(Preston	and	Macklin,	2015),	 served	as	animal	model	 to	gain	 further	 insights	 in	expression	and	









containing	 the	 binding	 and	 transmembrane	 domain	 of	 human	 and	 the	 intracellular	 loops	 of	
zebrafish	Gpr17	responded	to	MDL29,951	in	a	concentration-dependent	manner,	while	receptors	
exhibiting	 the	 zebrafish	 binding	 domain	 remained	 unresponsive.	 These	 preceded	 in	 vitro	 data	











(Chen	et	 al.,	 2009),	 suggesting	 a	 role	 of	Gpr17	 during	 zebrafish	 oligodendrocyte	 development.	
While	 transient	 OE	 of	 Gpr17	 did	 not	 affect	 developing	 oligodendrocytes	 or	 myelination,	 MO-
induced	 receptor	 knockdown	 led	 to	 significant	 reduction	 of	 dorsally	migrated	 pre-mature	 and	
mature	 oligodendrocyte	 numbers	 as	 well	 as	 impaired	 myelination.	 Additional	 experiments	
indicated	 a	 preceded	 pre-maturation	 of	 pre-OLs,	 which	 were	 restrained	 in	 the	 region	 of	 OPC	
specification	 and	 thus	 impaired	 to	 migrate	 and	 myelinate	 dorsal	 axons.	 These	 findings	
approximately	 correlate	 with	 data	 obtained	 in	 Gpr17	 knockout	 mice,	 demonstrating	 an	 early	
onset	 of	 oligodendrocyte	 maturation	 (Chen	 et	 al.,	 2009).	 Due	 to	 the	 dissimilarity	 between	
knockdown	and	knockout	methodologies,	 further	knockout	 studies	 in	 zebrafish	are	 required	 to	
finally	clarify	the	role	of	Gpr17	in	this	animal	model.	
In	 summary,	 the	 present	 study	 reveals	 that	 Gpr17	 notably	 contributes	 to	 oligodendrocyte	
development	 and	 myelination	 in	 zebrafish.	 Clearly,	 upcoming	 studies	 with	 Gpr17	 knockout	
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Supplementary	 Figure	 3:	 Tg(olig2:EGFP)	 zebrafish	 revealed	 impaired	mbp	 expression	 in	 CNS	 and	 PNS	
after	 zfAgpr17	 MO	 injections.	 Tg(olig2:EGFP)	 zebrafish,	 exhibiting	 a	 decrease	 in	 numbers	 of	 dorsally	
migrated	olig2	positive	OPCs	after	 injections	of	zfAgpr17	MO,	were	sorted	for	WISH	experiments.	Lateral	
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Supplementary	 Figure	 4:	 Chimeric	 Gpr17	 receptors	 exclusively	 couple	 via	 Gαi	 pathway.	 MDL29,951	
elicited	 DMR	 responses	 on	 3-HA	 tagged	 chimeric	 Gpr17	 transiently	 (A-C)	 and	 stably	 (D-F)	 expressed	 in	
HEK293	 cells.	 In	 the	 presence	 of	 PTX,	 responses	 of	 h+zfA	 (B)	 and	 h+zfBGpr17	 (E)	were	 abolished,	while	
stimulation	with	 UBO-QIC	merely	 eliminated	 carbachol	 signal	 (C,F).	 On	 the	 contrary,	 DMR	 responses	 of	
human	 Gpr17	 transiently	 expressed	 in	 HEK293	 cells	 (G-I)	 were	 diminished	 in	 the	 presence	 of	 both	
inhibitors,	 PTX	 (H)	 and	 UBO-QIC	 (I).	 Label-free	 recordings	 are	 shown	 as	 representative	 traces,	 each	
performed	 in	 triplicates	 (means	 +	 SEM).	 Data	 were	 generated	 by	 Dr.	 Nicole	Merten	 in	 the	 Institute	 of	
Pharmaceutical	Biology,	University	of	Bonn.	
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Figure	 14:	 Schematic	 prediction	 of	 chimeric	 h+zfA	 Gpr17	 receptor	 topology	 in	 the	 cell	
membrane..	..............................................................................................................................	76	
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